JPH0224544B2 - - Google Patents
Info
- Publication number
- JPH0224544B2 JPH0224544B2 JP56182729A JP18272981A JPH0224544B2 JP H0224544 B2 JPH0224544 B2 JP H0224544B2 JP 56182729 A JP56182729 A JP 56182729A JP 18272981 A JP18272981 A JP 18272981A JP H0224544 B2 JPH0224544 B2 JP H0224544B2
- Authority
- JP
- Japan
- Prior art keywords
- catheter
- maleic anhydride
- weight
- parts
- urinary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000002485 urinary effect Effects 0.000 claims description 34
- 239000000126 substance Substances 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 25
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims description 24
- 229920001577 copolymer Polymers 0.000 claims description 14
- 229920000642 polymer Polymers 0.000 claims description 14
- 239000003242 anti bacterial agent Substances 0.000 claims description 8
- 239000000178 monomer Substances 0.000 claims description 8
- 208000019206 urinary tract infection Diseases 0.000 claims description 8
- 125000001931 aliphatic group Chemical group 0.000 claims description 6
- 150000001993 dienes Chemical class 0.000 claims description 5
- 229920005573 silicon-containing polymer Polymers 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 claims description 3
- 150000001336 alkenes Chemical class 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 3
- 229920001567 vinyl ester resin Polymers 0.000 claims description 3
- 229920002554 vinyl polymer Polymers 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 2
- 229920000098 polyolefin Polymers 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 33
- 210000002700 urine Anatomy 0.000 description 29
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 20
- 239000000243 solution Substances 0.000 description 19
- 238000012360 testing method Methods 0.000 description 18
- 208000015181 infectious disease Diseases 0.000 description 15
- 241000894006 Bacteria Species 0.000 description 14
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 10
- -1 ethylene, propylene, 1-butene Chemical class 0.000 description 10
- 239000004372 Polyvinyl alcohol Substances 0.000 description 7
- 229940088710 antibiotic agent Drugs 0.000 description 7
- 229920002451 polyvinyl alcohol Polymers 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- JJCQSGDBDPYCEO-XVZSLQNASA-N dibekacin Chemical compound O1[C@H](CN)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N JJCQSGDBDPYCEO-XVZSLQNASA-N 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000007334 copolymerization reaction Methods 0.000 description 5
- 229920000768 polyamine Polymers 0.000 description 5
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 4
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 210000001635 urinary tract Anatomy 0.000 description 4
- NYEPHMYJRNWPLA-UHFFFAOYSA-N (6-amino-2-ethoxyacridin-9-yl)azanium;2-hydroxypropanoate;hydrate Chemical compound O.CC(O)C([O-])=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3[NH+]=C21 NYEPHMYJRNWPLA-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N 1-Heptene Chemical compound CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 2
- AFFLGGQVNFXPEV-UHFFFAOYSA-N 1-decene Chemical compound CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 2
- GQEZCXVZFLOKMC-UHFFFAOYSA-N 1-hexadecene Chemical compound CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 description 2
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 2
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 2
- WWUVJRULCWHUSA-UHFFFAOYSA-N 2-methyl-1-pentene Chemical compound CCCC(C)=C WWUVJRULCWHUSA-UHFFFAOYSA-N 0.000 description 2
- WSSSPWUEQFSQQG-UHFFFAOYSA-N 4-methyl-1-pentene Chemical compound CC(C)CC=C WSSSPWUEQFSQQG-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108010026389 Gramicidin Proteins 0.000 description 2
- 244000043261 Hevea brasiliensis Species 0.000 description 2
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 2
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 108010093965 Polymyxin B Proteins 0.000 description 2
- 108010040201 Polymyxins Proteins 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229940126575 aminoglycoside Drugs 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000011247 coating layer Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000019256 formaldehyde Nutrition 0.000 description 2
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000003120 macrolide antibiotic agent Substances 0.000 description 2
- 229940041033 macrolides Drugs 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- CKFGINPQOCXMAZ-UHFFFAOYSA-N methanediol Chemical compound OCO CKFGINPQOCXMAZ-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920003052 natural elastomer Polymers 0.000 description 2
- 229920001194 natural rubber Polymers 0.000 description 2
- CCCMONHAUSKTEQ-UHFFFAOYSA-N octadec-1-ene Chemical compound CCCCCCCCCCCCCCCCC=C CCCMONHAUSKTEQ-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000024 polymyxin B Polymers 0.000 description 2
- 229960005266 polymyxin b Drugs 0.000 description 2
- 229940041153 polymyxins Drugs 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- QJBZDBLBQWFTPZ-UHFFFAOYSA-N pyrrolnitrin Chemical compound [O-][N+](=O)C1=C(Cl)C=CC=C1C1=CNC=C1Cl QJBZDBLBQWFTPZ-UHFFFAOYSA-N 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- HPWIIERXAFODPP-GHBBWTPBSA-N (3r,4r)-3,6-diamino-n-[(3s,6z,9s,12s,15s)-3-[(6r)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide Chemical compound N1C(=O)\C(=C\NC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)C[C@@H](N)[C@H](O)CCN)CNC(=O)[C@@H]1[C@@H]1NC(=N)NCC1 HPWIIERXAFODPP-GHBBWTPBSA-N 0.000 description 1
- VCOPTHOUUNAYKQ-WBTCAYNUSA-N (3s)-3,6-diamino-n-[[(2s,5s,8e,11s,15s)-15-amino-11-[(6r)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;(3s)-3,6-diamino-n-[[(2s,5s,8 Chemical compound N1C(=O)\C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC(=O)[C@@H]1[C@@H]1NC(N)=NCC1.N1C(=O)\C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC(=O)[C@@H]1[C@@H]1NC(N)=NCC1 VCOPTHOUUNAYKQ-WBTCAYNUSA-N 0.000 description 1
- XIYOPDCBBDCGOE-IWVLMIASSA-N (4s,4ar,5s,5ar,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C=C1C2=CC=CC(O)=C2C(O)=C2[C@@H]1[C@H](O)[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O XIYOPDCBBDCGOE-IWVLMIASSA-N 0.000 description 1
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 1
- DHPRQBPJLMKORJ-XRNKAMNCSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O DHPRQBPJLMKORJ-XRNKAMNCSA-N 0.000 description 1
- PMJHHCWVYXUKFD-SNAWJCMRSA-N (E)-1,3-pentadiene Chemical compound C\C=C\C=C PMJHHCWVYXUKFD-SNAWJCMRSA-N 0.000 description 1
- MTZUIIAIAKMWLI-UHFFFAOYSA-N 1,2-diisocyanatobenzene Chemical compound O=C=NC1=CC=CC=C1N=C=O MTZUIIAIAKMWLI-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- PRBHEGAFLDMLAL-UHFFFAOYSA-N 1,5-Hexadiene Natural products CC=CCC=C PRBHEGAFLDMLAL-UHFFFAOYSA-N 0.000 description 1
- PGRNEGLBSNLPNP-UHFFFAOYSA-N 1,6-dichloro-3-methylhex-1-ene Chemical compound ClC=CC(C)CCCCl PGRNEGLBSNLPNP-UHFFFAOYSA-N 0.000 description 1
- PWGJDPKCLMLPJW-UHFFFAOYSA-N 1,8-diaminooctane Chemical compound NCCCCCCCCN PWGJDPKCLMLPJW-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- FPSURBCYSCOZSE-UHFFFAOYSA-N 1-ethenoxybutan-1-ol Chemical compound CCCC(O)OC=C FPSURBCYSCOZSE-UHFFFAOYSA-N 0.000 description 1
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 1
- VVJIVFKAROPUOS-UHFFFAOYSA-N 2,2-bis(aminomethyl)propane-1,3-diamine Chemical compound NCC(CN)(CN)CN VVJIVFKAROPUOS-UHFFFAOYSA-N 0.000 description 1
- HJKLEAOXCZIMPI-UHFFFAOYSA-N 2,2-diethoxyethanamine Chemical compound CCOC(CN)OCC HJKLEAOXCZIMPI-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical group C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical group C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- GHKSKVKCKMGRDU-UHFFFAOYSA-N 2-(3-aminopropylamino)ethanol Chemical compound NCCCNCCO GHKSKVKCKMGRDU-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- OZDGMOYKSFPLSE-UHFFFAOYSA-N 2-Methylaziridine Chemical compound CC1CN1 OZDGMOYKSFPLSE-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- ACTOXUHEUCPTEW-BWHGAVFKSA-N 2-[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2s,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-BWHGAVFKSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- PKXHXOTZMFCXSH-UHFFFAOYSA-N 3,3-dimethylbut-1-ene Chemical compound CC(C)(C)C=C PKXHXOTZMFCXSH-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical group N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- YHQXBTXEYZIYOV-UHFFFAOYSA-N 3-methylbut-1-ene Chemical compound CC(C)C=C YHQXBTXEYZIYOV-UHFFFAOYSA-N 0.000 description 1
- LDTAOIUHUHHCMU-UHFFFAOYSA-N 3-methylpent-1-ene Chemical compound CCC(C)C=C LDTAOIUHUHHCMU-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- SUWJESCICIOQHO-UHFFFAOYSA-N 4-methylhex-1-ene Chemical compound CCC(C)CC=C SUWJESCICIOQHO-UHFFFAOYSA-N 0.000 description 1
- JIUFYGIESXPUPL-UHFFFAOYSA-N 5-methylhex-1-ene Chemical compound CC(C)CCC=C JIUFYGIESXPUPL-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical group C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
- 108010065839 Capreomycin Proteins 0.000 description 1
- UQLLWWBDSUHNEB-CZUORRHYSA-N Cefaprin Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C(O)=O)C(=O)CSC1=CC=NC=C1 UQLLWWBDSUHNEB-CZUORRHYSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 108010078777 Colistin Proteins 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- DYDCUQKUCUHJBH-UHFFFAOYSA-N D-Cycloserine Natural products NC1CONC1=O DYDCUQKUCUHJBH-UHFFFAOYSA-N 0.000 description 1
- DYDCUQKUCUHJBH-UWTATZPHSA-N D-Cycloserine Chemical compound N[C@@H]1CONC1=O DYDCUQKUCUHJBH-UWTATZPHSA-N 0.000 description 1
- 108010092160 Dactinomycin Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 108010038532 Enviomycin Proteins 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- DMUAPQTXSSNEDD-QALJCMCCSA-N Midecamycin Chemical compound C1[C@](O)(C)[C@@H](OC(=O)CC)[C@H](C)O[C@H]1O[C@H]1[C@H](N(C)C)[C@@H](O)[C@H](O[C@@H]2[C@H]([C@H](OC(=O)CC)CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O)[C@H](C)C[C@@H]2CC=O)OC)O[C@@H]1C DMUAPQTXSSNEDD-QALJCMCCSA-N 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- BZORFPDSXLZWJF-UHFFFAOYSA-N N,N-dimethyl-1,4-phenylenediamine Chemical compound CN(C)C1=CC=C(N)C=C1 BZORFPDSXLZWJF-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 101710204212 Neocarzinostatin Proteins 0.000 description 1
- 239000004104 Oleandomycin Substances 0.000 description 1
- RZPAKFUAFGMUPI-UHFFFAOYSA-N Oleandomycin Natural products O1C(C)C(O)C(OC)CC1OC1C(C)C(=O)OC(C)C(C)C(O)C(C)C(=O)C2(OC2)CC(C)C(OC2C(C(CC(C)O2)N(C)C)O)C1C RZPAKFUAFGMUPI-UHFFFAOYSA-N 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- UOZODPSAJZTQNH-UHFFFAOYSA-N Paromomycin II Natural products NC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)CC(N)C2O)OC2C(C(O)C(O)C(CO)O2)N)OC1CO UOZODPSAJZTQNH-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- NCXMLFZGDNKEPB-UHFFFAOYSA-N Pimaricin Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCC(C)OC(=O)C=CC2OC2CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 NCXMLFZGDNKEPB-UHFFFAOYSA-N 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 239000004187 Spiramycin Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- GKXVJHDEWHKBFH-UHFFFAOYSA-N [2-(aminomethyl)phenyl]methanamine Chemical compound NCC1=CC=CC=C1CN GKXVJHDEWHKBFH-UHFFFAOYSA-N 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 229930183665 actinomycin Natural products 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229960004821 amikacin Drugs 0.000 description 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- IMUDHTPIFIBORV-UHFFFAOYSA-N aminoethylpiperazine Chemical compound NCCN1CCNCC1 IMUDHTPIFIBORV-UHFFFAOYSA-N 0.000 description 1
- 229940126574 aminoglycoside antibiotic Drugs 0.000 description 1
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 229960001192 bekanamycin Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940053013 bio-mycin Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- RGTXVXDNHPWPHH-UHFFFAOYSA-N butane-1,3-diamine Chemical compound CC(N)CCN RGTXVXDNHPWPHH-UHFFFAOYSA-N 0.000 description 1
- GHWVXCQZPNWFRO-UHFFFAOYSA-N butane-2,3-diamine Chemical compound CC(N)C(C)N GHWVXCQZPNWFRO-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960004602 capreomycin Drugs 0.000 description 1
- 229950004030 cefaloglycin Drugs 0.000 description 1
- FUBBGQLTSCSAON-PBFPGSCMSA-N cefaloglycin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)C)C(O)=O)=CC=CC=C1 FUBBGQLTSCSAON-PBFPGSCMSA-N 0.000 description 1
- 229960004350 cefapirin Drugs 0.000 description 1
- 229960001139 cefazolin Drugs 0.000 description 1
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 1
- WZOZEZRFJCJXNZ-ZBFHGGJFSA-N cefoxitin Chemical compound N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)CC1=CC=CS1 WZOZEZRFJCJXNZ-ZBFHGGJFSA-N 0.000 description 1
- 229960002682 cefoxitin Drugs 0.000 description 1
- 229940106164 cephalexin Drugs 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- JQXXHWHPUNPDRT-YOPQJBRCSA-N chembl1332716 Chemical compound O([C@](C1=O)(C)O\C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CCN(C)CC1 JQXXHWHPUNPDRT-YOPQJBRCSA-N 0.000 description 1
- YACLQRRMGMJLJV-UHFFFAOYSA-N chloroprene Chemical compound ClC(=C)C=C YACLQRRMGMJLJV-UHFFFAOYSA-N 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960003326 cloxacillin Drugs 0.000 description 1
- LQOLIRLGBULYKD-JKIFEVAISA-N cloxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl LQOLIRLGBULYKD-JKIFEVAISA-N 0.000 description 1
- 229960003346 colistin Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229960004244 cyclacillin Drugs 0.000 description 1
- HGBLNBBNRORJKI-WCABBAIRSA-N cyclacillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C1(N)CCCCC1 HGBLNBBNRORJKI-WCABBAIRSA-N 0.000 description 1
- CFBGXYDUODCMNS-UHFFFAOYSA-N cyclobutene Chemical compound C1CC=C1 CFBGXYDUODCMNS-UHFFFAOYSA-N 0.000 description 1
- PDXRQENMIVHKPI-UHFFFAOYSA-N cyclohexane-1,1-diol Chemical compound OC1(O)CCCCC1 PDXRQENMIVHKPI-UHFFFAOYSA-N 0.000 description 1
- 229960003077 cycloserine Drugs 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 229960000975 daunorubicin Drugs 0.000 description 1
- YQLZOAVZWJBZSY-UHFFFAOYSA-N decane-1,10-diamine Chemical compound NCCCCCCCCCCN YQLZOAVZWJBZSY-UHFFFAOYSA-N 0.000 description 1
- 229960003807 dibekacin Drugs 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 229960001585 dicloxacillin Drugs 0.000 description 1
- YFAGHNZHGGCZAX-JKIFEVAISA-N dicloxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl YFAGHNZHGGCZAX-JKIFEVAISA-N 0.000 description 1
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- QFTYSVGGYOXFRQ-UHFFFAOYSA-N dodecane-1,12-diamine Chemical compound NCCCCCCCCCCCCN QFTYSVGGYOXFRQ-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960004679 doxorubicin Drugs 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000005053 encephalomalacia Diseases 0.000 description 1
- 229950000219 enviomycin Drugs 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- LDLDYFCCDKENPD-UHFFFAOYSA-N ethenylcyclohexane Chemical compound C=CC1CCCCC1 LDLDYFCCDKENPD-UHFFFAOYSA-N 0.000 description 1
- YIWFBNMYFYINAD-UHFFFAOYSA-N ethenylcyclopropane Chemical compound C=CC1CC1 YIWFBNMYFYINAD-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960004273 floxacillin Drugs 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960004905 gramicidin Drugs 0.000 description 1
- IUAYMJGZBVDSGL-XNNAEKOYSA-N gramicidin S Chemical compound C([C@@H]1C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CCCN)C(=O)N[C@H](C(N[C@H](CC=2C=CC=CC=2)C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1)C(C)C)=O)CC(C)C)C(C)C)C1=CC=CC=C1 IUAYMJGZBVDSGL-XNNAEKOYSA-N 0.000 description 1
- 229950009774 gramicidin s Drugs 0.000 description 1
- ZWCXYZRRTRDGQE-SORVKSEFSA-N gramicidina Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)CC(C)C)C(=O)NCCO)=CNC2=C1 ZWCXYZRRTRDGQE-SORVKSEFSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- GEAWFZNTIFJMHR-UHFFFAOYSA-N hepta-1,6-diene Chemical compound C=CCCCC=C GEAWFZNTIFJMHR-UHFFFAOYSA-N 0.000 description 1
- 229960003884 hetacillin Drugs 0.000 description 1
- DXVUYOAEDJXBPY-NFFDBFGFSA-N hetacillin Chemical compound C1([C@@H]2C(=O)N(C(N2)(C)C)[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 DXVUYOAEDJXBPY-NFFDBFGFSA-N 0.000 description 1
- PYGSKMBEVAICCR-UHFFFAOYSA-N hexa-1,5-diene Chemical compound C=CCCC=C PYGSKMBEVAICCR-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- SKKLOUVUUNMCJE-FQSMHNGLSA-N kanamycin B Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SKKLOUVUUNMCJE-FQSMHNGLSA-N 0.000 description 1
- 229930182824 kanamycin B Natural products 0.000 description 1
- SKKLOUVUUNMCJE-UHFFFAOYSA-N kanendomycin Natural products NC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)C(O)C(CO)O2)O)C(N)CC1N SKKLOUVUUNMCJE-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 229950007634 kitasamycin Drugs 0.000 description 1
- XYJOGTQLTFNMQG-KJHBSLKPSA-N leucomycin V Chemical compound CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](N(C)C)[C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1 XYJOGTQLTFNMQG-KJHBSLKPSA-N 0.000 description 1
- 229960005287 lincomycin Drugs 0.000 description 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940042016 methacycline Drugs 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 229960002757 midecamycin Drugs 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- QOHMWDJIBGVPIF-UHFFFAOYSA-N n',n'-diethylpropane-1,3-diamine Chemical compound CCN(CC)CCCN QOHMWDJIBGVPIF-UHFFFAOYSA-N 0.000 description 1
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 1
- ZUXUNWLVIWKEHB-UHFFFAOYSA-N n',n'-dimethylhexane-1,6-diamine Chemical compound CN(C)CCCCCCN ZUXUNWLVIWKEHB-UHFFFAOYSA-N 0.000 description 1
- KMBPCQSCMCEPMU-UHFFFAOYSA-N n'-(3-aminopropyl)-n'-methylpropane-1,3-diamine Chemical compound NCCCN(C)CCCN KMBPCQSCMCEPMU-UHFFFAOYSA-N 0.000 description 1
- IMENJLNZKOMSMC-UHFFFAOYSA-N n'-[2-[2-[2-[2-[2-(2-aminoethylamino)ethylamino]ethylamino]ethylamino]ethylamino]ethyl]ethane-1,2-diamine Chemical compound NCCNCCNCCNCCNCCNCCNCCN IMENJLNZKOMSMC-UHFFFAOYSA-N 0.000 description 1
- QHJABUZHRJTCAR-UHFFFAOYSA-N n'-methylpropane-1,3-diamine Chemical compound CNCCCN QHJABUZHRJTCAR-UHFFFAOYSA-N 0.000 description 1
- HDCAZTXEZQWTIJ-UHFFFAOYSA-N n,n',n'-triethylethane-1,2-diamine Chemical compound CCNCCN(CC)CC HDCAZTXEZQWTIJ-UHFFFAOYSA-N 0.000 description 1
- VEAZEPMQWHPHAG-UHFFFAOYSA-N n,n,n',n'-tetramethylbutane-1,4-diamine Chemical compound CN(C)CCCCN(C)C VEAZEPMQWHPHAG-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 description 1
- PZMRMZQWGOESGV-UHFFFAOYSA-N n-ethyl-2-ethyliminoethanamine Chemical compound CCNCC=NCC PZMRMZQWGOESGV-UHFFFAOYSA-N 0.000 description 1
- HALVJFMEOOBLMQ-UHFFFAOYSA-N n-ethyl-2-methyliminoethanamine Chemical compound CCNCC=NC HALVJFMEOOBLMQ-UHFFFAOYSA-N 0.000 description 1
- 229960003255 natamycin Drugs 0.000 description 1
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- QZGIWPZCWHMVQL-UIYAJPBUSA-N neocarzinostatin chromophore Chemical compound O1[C@H](C)[C@H](O)[C@H](O)[C@@H](NC)[C@H]1O[C@@H]1C/2=C/C#C[C@H]3O[C@@]3([C@@H]3OC(=O)OC3)C#CC\2=C[C@H]1OC(=O)C1=C(O)C=CC2=C(C)C=C(OC)C=C12 QZGIWPZCWHMVQL-UIYAJPBUSA-N 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- SXJVFQLYZSNZBT-UHFFFAOYSA-N nonane-1,9-diamine Chemical compound NCCCCCCCCCN SXJVFQLYZSNZBT-UHFFFAOYSA-N 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- RZPAKFUAFGMUPI-KGIGTXTPSA-N oleandomycin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](O)[C@@H](C)C(=O)[C@]2(OC2)C[C@H](C)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C RZPAKFUAFGMUPI-KGIGTXTPSA-N 0.000 description 1
- 229960002351 oleandomycin Drugs 0.000 description 1
- 235000019367 oleandomycin Nutrition 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- UOZODPSAJZTQNH-LSWIJEOBSA-N paromomycin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO UOZODPSAJZTQNH-LSWIJEOBSA-N 0.000 description 1
- 229960001914 paromomycin Drugs 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- JGQDLMSXMOGEMC-UHFFFAOYSA-N pentane-2,4-diamine Chemical compound CC(N)CC(C)N JGQDLMSXMOGEMC-UHFFFAOYSA-N 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229960002292 piperacillin Drugs 0.000 description 1
- IVBHGBMCVLDMKU-GXNBUGAJSA-N piperacillin Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 IVBHGBMCVLDMKU-GXNBUGAJSA-N 0.000 description 1
- PMJHHCWVYXUKFD-UHFFFAOYSA-N piperylene Natural products CC=CC=C PMJHHCWVYXUKFD-UHFFFAOYSA-N 0.000 description 1
- 150000004291 polyenes Chemical class 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000005056 polyisocyanate Substances 0.000 description 1
- 229920001228 polyisocyanate Polymers 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 description 1
- KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- AOHJOMMDDJHIJH-UHFFFAOYSA-N propylenediamine Chemical compound CC(N)CN AOHJOMMDDJHIJH-UHFFFAOYSA-N 0.000 description 1
- 201000004537 pyelitis Diseases 0.000 description 1
- 229960002132 pyrrolnitrin Drugs 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- NSKGQURZWSPSBC-NLZFXWNVSA-N ribostamycin Chemical compound N[C@H]1[C@H](O)[C@@H](O)[C@H](CN)O[C@@H]1O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](CO)O2)O)[C@H](O)[C@@H](N)C[C@H]1N NSKGQURZWSPSBC-NLZFXWNVSA-N 0.000 description 1
- 229960003485 ribostamycin Drugs 0.000 description 1
- 229930190553 ribostamycin Natural products 0.000 description 1
- NSKGQURZWSPSBC-UHFFFAOYSA-N ribostamycin A Natural products NC1C(O)C(O)C(CN)OC1OC1C(OC2C(C(O)C(CO)O2)O)C(O)C(N)CC1N NSKGQURZWSPSBC-UHFFFAOYSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 229960001294 spiramycin Drugs 0.000 description 1
- 235000019372 spiramycin Nutrition 0.000 description 1
- 229930191512 spiramycin Natural products 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000012612 static experiment Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 229960002780 talampicillin Drugs 0.000 description 1
- SOROUYSPFADXSN-SUWVAFIASA-N talampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(=O)OC2C3=CC=CC=C3C(=O)O2)(C)C)=CC=CC=C1 SOROUYSPFADXSN-SUWVAFIASA-N 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- FAGUFWYHJQFNRV-UHFFFAOYSA-N tetraethylenepentamine Chemical compound NCCNCCNCCNCCN FAGUFWYHJQFNRV-UHFFFAOYSA-N 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 229960000707 tobramycin Drugs 0.000 description 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 1
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- MBYLVOKEDDQJDY-UHFFFAOYSA-N tris(2-aminoethyl)amine Chemical compound NCCN(CCN)CCN MBYLVOKEDDQJDY-UHFFFAOYSA-N 0.000 description 1
- KLNPWTHGTVSSEU-UHFFFAOYSA-N undecane-1,11-diamine Chemical compound NCCCCCCCCCCCN KLNPWTHGTVSSEU-UHFFFAOYSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 229950009268 zinostatin Drugs 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯ããªã¬ãã€ã³ç³»éåäœãŸãã¯ãžãšã³ç³»
éåäœãŸãã¯ã·ãªã³ã³ç³»éåäœãçŽ æãšããŠäœæ
ããããå°¿è·¯ææé²æ¢èœãæããå°å°¿ã«ããŒãã«
ã®è£œé æ³ã«é¢ãããã®ã§ããã
éåäœãŸãã¯ã·ãªã³ã³ç³»éåäœãçŽ æãšããŠäœæ
ããããå°¿è·¯ææé²æ¢èœãæããå°å°¿ã«ããŒãã«
ã®è£œé æ³ã«é¢ãããã®ã§ããã
èé«æå·ãè³åºè¡ãè³è»åçãæè¡åŸã®æ£è
ã«
ãããŠã¯æå°¿å°é£ã尿倱çŠãªã©ã®çç¶ã䌎ãããš
ãå€ãããã®ãããªå Žåã«ã¯ãåæ»ãªå°¿è·¯ã確ä¿
ãããã®çµæãè æ©èœã®ç¶æãæ¹åãä¿ãããã
ãã¯å°¿ã®æŒåºãé²æ¢ãããšãã€ãæå³ã§ã«ããŒã
ã«ãçšããå°å°¿æ³ãæ¡çšãããããã®éã«çšãã
ããã«ããŒãã«ã¯ç¹ã«å°å°¿ã«ããŒãã«ãšç§°ããã
ãã®çšéäžããå åãªæè»æ§ã匟åæ§ããã³äººäœ
ç¡å®³æ§ãæããããšãå¿ èŠã§ãããã»ãšãã©ã¯ãª
ã¬ãã€ã³ç³»éåäœãŸãã¯ãžãšã³ç³»éåäœãŸãã¯ã·
ãªã³ã³ç³»éåäœãçŽ æãšããŠäœæãããŠããã
ãããŠã¯æå°¿å°é£ã尿倱çŠãªã©ã®çç¶ã䌎ãããš
ãå€ãããã®ãããªå Žåã«ã¯ãåæ»ãªå°¿è·¯ã確ä¿
ãããã®çµæãè æ©èœã®ç¶æãæ¹åãä¿ãããã
ãã¯å°¿ã®æŒåºãé²æ¢ãããšãã€ãæå³ã§ã«ããŒã
ã«ãçšããå°å°¿æ³ãæ¡çšãããããã®éã«çšãã
ããã«ããŒãã«ã¯ç¹ã«å°å°¿ã«ããŒãã«ãšç§°ããã
ãã®çšéäžããå åãªæè»æ§ã匟åæ§ããã³äººäœ
ç¡å®³æ§ãæããããšãå¿ èŠã§ãããã»ãšãã©ã¯ãª
ã¬ãã€ã³ç³»éåäœãŸãã¯ãžãšã³ç³»éåäœãŸãã¯ã·
ãªã³ã³ç³»éåäœãçŽ æãšããŠäœæãããŠããã
å°å°¿æ³ã¯æå°¿ãéããã«è¡ããããšãã€ã極ã
ãŠæçšãªæ²»çæ段ã§ããããæ³å°¿åšç§ã®ã¿ãªã
ããå€ç§ãå ç§ãç£å©Šäººç§ãªã©ã®é åã§æ¥åžžçã«
ç¹çšãããŠããããäžæ¹ã§ã¯ããã€ããå°å°¿ã«ã
ãŒãã«ãå°¿è·¯ã«ç眮ããããšææã®çºçã¯é¿ãé£
ããšããåé¡ããããããªãã¡ãå°å°¿ã«ããŒãã«
ã¯é·æéå°¿è·¯ã«ç眮ããŠãããã®ã§ãããããã
ã®ã«ããŒãã«ãéããŠçŽ°èãäŸµå ¥ããå°¿éçãè
è±çè ãçãªã©ã®çç¶ãé »çºãããåŸæ¥ããå€çš
ãããŠããéæŸæç¶å°å°¿æ³ïŒç¡åç¶ãªã©æ» èãã
ãŠããªã容åšã«éå°¿ããæ¹æ³ïŒãæœè¡ããå Žåã«
ã¯ãïŒæ¥ä»¥å ã«42ã80ïŒ ã®çäŸã«ææãçºçãã
ïŒæ¥ç®ã«ã¯å šäŸã«ææãæç«ããããšãå ±åãã
ãŠããã
ãŠæçšãªæ²»çæ段ã§ããããæ³å°¿åšç§ã®ã¿ãªã
ããå€ç§ãå ç§ãç£å©Šäººç§ãªã©ã®é åã§æ¥åžžçã«
ç¹çšãããŠããããäžæ¹ã§ã¯ããã€ããå°å°¿ã«ã
ãŒãã«ãå°¿è·¯ã«ç眮ããããšææã®çºçã¯é¿ãé£
ããšããåé¡ããããããªãã¡ãå°å°¿ã«ããŒãã«
ã¯é·æéå°¿è·¯ã«ç眮ããŠãããã®ã§ãããããã
ã®ã«ããŒãã«ãéããŠçŽ°èãäŸµå ¥ããå°¿éçãè
è±çè ãçãªã©ã®çç¶ãé »çºãããåŸæ¥ããå€çš
ãããŠããéæŸæç¶å°å°¿æ³ïŒç¡åç¶ãªã©æ» èãã
ãŠããªã容åšã«éå°¿ããæ¹æ³ïŒãæœè¡ããå Žåã«
ã¯ãïŒæ¥ä»¥å ã«42ã80ïŒ ã®çäŸã«ææãçºçãã
ïŒæ¥ç®ã«ã¯å šäŸã«ææãæç«ããããšãå ±åãã
ãŠããã
ãã®ããå°¿è·¯ææé²æ¢ã«é¢ããŠã¯èè±ã®æŽæµã
殺èå€ã®æ³šå ¥ãªã©ã®æ¹æ³ãè¡ãããŠããããæäœ
ãé¢åã§ããããŸããã®æäœãè¡ãããšèªäœãæ°
ããªæææºãšãªããšãã€ãäžéœåãªé¢ãå€ãã
殺èå€ã®æ³šå ¥ãªã©ã®æ¹æ³ãè¡ãããŠããããæäœ
ãé¢åã§ããããŸããã®æäœãè¡ãããšèªäœãæ°
ããªæææºãšãªããšãã€ãäžéœåãªé¢ãå€ãã
ãŸããæèç©è³ªã®äºé²çæäžãªã©ã®ååŠçæ³ã
è¡ãããŠãããã倧éæäžãããã¯æèç©è³ªã®çš®
é¡ã«ãã€ãŠã¯å°éã«ãŠãé »çºããå¯äœçšã®åé¡ã
ãã³äžããææãçãããšè亀代çãçºçŸããã
ãããšãªã©ã®åé¡ããç¡èšç»ãªååŠçæ³ã¯ããã
æ害ã§ãããšèšãããçšã«æèç©è³ªã«é¢ããŠã¯å±
æçå©çšã匷ãæãŸããŠããã
è¡ãããŠãããã倧éæäžãããã¯æèç©è³ªã®çš®
é¡ã«ãã€ãŠã¯å°éã«ãŠãé »çºããå¯äœçšã®åé¡ã
ãã³äžããææãçãããšè亀代çãçºçŸããã
ãããšãªã©ã®åé¡ããç¡èšç»ãªååŠçæ³ã¯ããã
æ害ã§ãããšèšãããçšã«æèç©è³ªã«é¢ããŠã¯å±
æçå©çšã匷ãæãŸããŠããã
æèç©è³ªã®å±æçå©çšã«é¢ããŠã¯ãå°å°¿ã«ããŒ
ãã«ã«æèç©è³ªå ¥ãã®è»èãå¡åžããããå£é¢ã«
æš¹èãã³ãŒãã€ã³ã°ããã®ã³ãŒãã€ã³ã°å±€ã«æè
ç©è³ªãå«ãŸããŠäœ¿çšãããšãã€ãæ¹æ³ïŒç¹å ¬æ54
â27680å·ïŒãææ¡ãããŠãããããããã®æ¹æ³
ã«ããå Žåãæèç©è³ªã¯æ¯æå±€ã«åžçãããŠãã
ã ãã§ãããããäœå ç眮åŸæ¥µããŠçæéã«æè
ç©è³ªã¯å°¿ã«ãã€ãŠæŽãæµããäœå€ã«æµåºããæè
æ©èœãèªããããªããªãããšããæºè¶³ã«äœ¿çšãã
ããã®ã§ã¯ãªãã
ãã«ã«æèç©è³ªå ¥ãã®è»èãå¡åžããããå£é¢ã«
æš¹èãã³ãŒãã€ã³ã°ããã®ã³ãŒãã€ã³ã°å±€ã«æè
ç©è³ªãå«ãŸããŠäœ¿çšãããšãã€ãæ¹æ³ïŒç¹å ¬æ54
â27680å·ïŒãææ¡ãããŠãããããããã®æ¹æ³
ã«ããå Žåãæèç©è³ªã¯æ¯æå±€ã«åžçãããŠãã
ã ãã§ãããããäœå ç眮åŸæ¥µããŠçæéã«æè
ç©è³ªã¯å°¿ã«ãã€ãŠæŽãæµããäœå€ã«æµåºããæè
æ©èœãèªããããªããªãããšããæºè¶³ã«äœ¿çšãã
ããã®ã§ã¯ãªãã
ãŸããã¹ãªãŒãŠãšã€ã«ããŒãã«ãšåŒã°ãããã®
ãçšããŠæèç©è³ªåžé溶液ãèè±å ã«çŽæ¥ç¹æ»Žã
ãæ¹æ³ãªã©ãå±æçæ²»çæ³ãšããŠãšãããŠãã
ããåæ±ããå°é£ã§é¢åãªãããäžéšã®æ³å°¿åšç§
ã§æ¡çšãããŠããã«ããããä»ã®èšåºé åã§ã¯çš
ããããŠããªãã®ãçŸç¶ã§ããã
ãçšããŠæèç©è³ªåžé溶液ãèè±å ã«çŽæ¥ç¹æ»Žã
ãæ¹æ³ãªã©ãå±æçæ²»çæ³ãšããŠãšãããŠãã
ããåæ±ããå°é£ã§é¢åãªãããäžéšã®æ³å°¿åšç§
ã§æ¡çšãããŠããã«ããããä»ã®èšåºé åã§ã¯çš
ããããŠããªãã®ãçŸç¶ã§ããã
现èã®äŸµå
¥çµè·¯ãšããŠã¯å°å°¿ã«ããŒãã«ãšå°¿
è·¯ç²èã®ééãéè¡ïŒç®¡å€æ§çµè·¯ïŒãå°å°¿ã«ã
ãŒãã«ãšå°ç®¡ãšã®çµåéšããã®äŸµå ¥ïŒæŽæµãªã©ã®
åŠçœ®ãå«ãïŒãèå°¿éšããå°ç®¡ããã³å°å°¿ã«ã
ãŒãã«å éšã®éè¡ïŒç®¡å æ§çµè·¯ïŒãããã管å€æ§
çµè·¯ããã®äŸµå ¥ã«ãŠã¯å°¿éåžžå§èãç眮åŸæ©æã«
ã¯å°å°¿ã«ããŒãã«ã®å£ãäŒã€ãŠéããã«äžè¡ãã
èè±é éšã«éããããã®ãããªææã«å¯ŸããŠã¯å°
å°¿ã«ããŒãã«ã®å£é¢ã«ååšããæèç©è³ªã¯çŽæ¥è
ãšæ¥ããããšãã§ããã®ã§æèæ©èœãçºæ®ãåŸ
ããããããªãã管å æ§çµè·¯ãäŸãã°éå°¿åšãã
ã®äŸµå ¥ãããªãã¡éå°¿åšã«èœäžãããã¯äŸµå ¥ãã
现èã¯ã貯çããŠããå°¿äžã§å¢æ®ããå°¿ã®éæµã
æ°æ³¡ã®äžæã«äŒŽã€ãŠèè±èã«ãŸã§éãããå®éã
é眮å®éšã«ãããŠé¯ã®æ»æãã®ããšãã«çŽ°èãå°¿
äžãé¡ãããšã確èªãããŠããããã®ãããªçµè·¯
ããã®äŸµå ¥ã«å¯ŸããŠã¯ãå°å°¿ã«ããŒãã«ã®å£é¢ã«
ååšããæèç©è³ªã¯èãšçŽæ¥æ¥ããããšãã§ããª
ãããšãèµ·ããåŸããããæèæ©èœã®åã°ãªãè
ãæ®åããå¯èœæ§ãé«ããææé²æ¢èœåã¯å åã§
ã¯ãªããå šãŠã®äŸµå ¥çµè·¯ããã®ææã«å¯ŸããŠé²æ¢
èœåãæã€ããã«ã¯ãæèç©è³ªã¯å°å°¿ã«ããŒãã«
ã®å£é¢ã«ååšããã ãã§ãªããé€ã ã«å£é¢ããé¢
ããŠå°¿äžã«æ¡æ£ããŠãããå°¿å ãæµ®éäžåãã现
èã«æ¥ããããšãå¿ èŠã§ããããã®å Žåãæèç©
質ãå£é¢ããé¢ããŠããéã®é床ãåé¡ãšãªãã
åè¿°ã®ããšãå°å°¿ã«ããŒãã«ã«æèç©è³ªãåžçã
ããããæèç©è³ªå ¥ãã®è»èãå¡åžãããããã
ã¯å£é¢ã«æš¹èãã³ãŒãã€ã³ã°ãããã®ã³ãŒãã€ã³
ã°å±€ã«æèç©è³ªãå«ãŸããŠäœ¿çšãããããšãæ¹æ³
ãå®æœããå Žåã«ã¯ãæèç©è³ªã¯å°¿ã«ãã€ãŠç°¡å
ã«æŽãæµããäœå€ã¯æµåºãã極ããŠçæéã«ãŠå£
é¢ã«ãå°¿äžã«ãååšããªããªãããã®ããšã¯æ¥µã
ãŠçæéã®äœå ç眮ã«ãŠææé²æ¢èœåãå šã倱ãª
ãããããšãæå³ãããåŸã€ãŠãæèç©è³ªãå£é¢
ããé¢ããŠããé床ãå¶åŸ¡ããé·æéã«ããã€ãŠ
æèç©è³ªã®å°¿äžæ¿åºŠãæå¹ãªæ¿åºŠä»¥äžã«ä¿ã€ãŠã
ãããšãææé²æ¢ã«ã¯å€§åãªããšãšãªãã
è·¯ç²èã®ééãéè¡ïŒç®¡å€æ§çµè·¯ïŒãå°å°¿ã«ã
ãŒãã«ãšå°ç®¡ãšã®çµåéšããã®äŸµå ¥ïŒæŽæµãªã©ã®
åŠçœ®ãå«ãïŒãèå°¿éšããå°ç®¡ããã³å°å°¿ã«ã
ãŒãã«å éšã®éè¡ïŒç®¡å æ§çµè·¯ïŒãããã管å€æ§
çµè·¯ããã®äŸµå ¥ã«ãŠã¯å°¿éåžžå§èãç眮åŸæ©æã«
ã¯å°å°¿ã«ããŒãã«ã®å£ãäŒã€ãŠéããã«äžè¡ãã
èè±é éšã«éããããã®ãããªææã«å¯ŸããŠã¯å°
å°¿ã«ããŒãã«ã®å£é¢ã«ååšããæèç©è³ªã¯çŽæ¥è
ãšæ¥ããããšãã§ããã®ã§æèæ©èœãçºæ®ãåŸ
ããããããªãã管å æ§çµè·¯ãäŸãã°éå°¿åšãã
ã®äŸµå ¥ãããªãã¡éå°¿åšã«èœäžãããã¯äŸµå ¥ãã
现èã¯ã貯çããŠããå°¿äžã§å¢æ®ããå°¿ã®éæµã
æ°æ³¡ã®äžæã«äŒŽã€ãŠèè±èã«ãŸã§éãããå®éã
é眮å®éšã«ãããŠé¯ã®æ»æãã®ããšãã«çŽ°èãå°¿
äžãé¡ãããšã確èªãããŠããããã®ãããªçµè·¯
ããã®äŸµå ¥ã«å¯ŸããŠã¯ãå°å°¿ã«ããŒãã«ã®å£é¢ã«
ååšããæèç©è³ªã¯èãšçŽæ¥æ¥ããããšãã§ããª
ãããšãèµ·ããåŸããããæèæ©èœã®åã°ãªãè
ãæ®åããå¯èœæ§ãé«ããææé²æ¢èœåã¯å åã§
ã¯ãªããå šãŠã®äŸµå ¥çµè·¯ããã®ææã«å¯ŸããŠé²æ¢
èœåãæã€ããã«ã¯ãæèç©è³ªã¯å°å°¿ã«ããŒãã«
ã®å£é¢ã«ååšããã ãã§ãªããé€ã ã«å£é¢ããé¢
ããŠå°¿äžã«æ¡æ£ããŠãããå°¿å ãæµ®éäžåãã现
èã«æ¥ããããšãå¿ èŠã§ããããã®å Žåãæèç©
質ãå£é¢ããé¢ããŠããéã®é床ãåé¡ãšãªãã
åè¿°ã®ããšãå°å°¿ã«ããŒãã«ã«æèç©è³ªãåžçã
ããããæèç©è³ªå ¥ãã®è»èãå¡åžãããããã
ã¯å£é¢ã«æš¹èãã³ãŒãã€ã³ã°ãããã®ã³ãŒãã€ã³
ã°å±€ã«æèç©è³ªãå«ãŸããŠäœ¿çšãããããšãæ¹æ³
ãå®æœããå Žåã«ã¯ãæèç©è³ªã¯å°¿ã«ãã€ãŠç°¡å
ã«æŽãæµããäœå€ã¯æµåºãã極ããŠçæéã«ãŠå£
é¢ã«ãå°¿äžã«ãååšããªããªãããã®ããšã¯æ¥µã
ãŠçæéã®äœå ç眮ã«ãŠææé²æ¢èœåãå šã倱ãª
ãããããšãæå³ãããåŸã€ãŠãæèç©è³ªãå£é¢
ããé¢ããŠããé床ãå¶åŸ¡ããé·æéã«ããã€ãŠ
æèç©è³ªã®å°¿äžæ¿åºŠãæå¹ãªæ¿åºŠä»¥äžã«ä¿ã€ãŠã
ãããšãææé²æ¢ã«ã¯å€§åãªããšãšãªãã
æ¬çºæè
ãã¯ããã®ãããªçŸç¶ã«éã¿ã簡䟿ã«
䜿çšã§ããæ°ããªæææºãšãªãããšããªããé·æ
éã«ããã€ãŠç·ãŠã®äŸµå ¥çµè·¯ããã®ææã«ãé²æ¢
èœåãæããå°å°¿ã«ããŒãã«ãæäŸããããšãç®
çãšããŠéæç 究ãéããçµæãç¹å®ã®ç¡æ°Žãã¬
ã€ã³é žç³»å ±éåäœã®æ··åç©ãšãããšåå¿ãåŸãå€
å®èœæ§ååç©ãšã®åå¿çæç©ã«æèç©è³ªãçµåã
ããéã«ãæèç©è³ªãåŸã ã«åå¿çæç©ããé¢ã
ãŠããããšãèŠåºãããã®çŸè±¡ãå°å°¿ã«ããŒãã«
ã«å¿çšããããšã«æå·§ããæ¬çºæã«å°éãããã®
ã§ããã
䜿çšã§ããæ°ããªæææºãšãªãããšããªããé·æ
éã«ããã€ãŠç·ãŠã®äŸµå ¥çµè·¯ããã®ææã«ãé²æ¢
èœåãæããå°å°¿ã«ããŒãã«ãæäŸããããšãç®
çãšããŠéæç 究ãéããçµæãç¹å®ã®ç¡æ°Žãã¬
ã€ã³é žç³»å ±éåäœã®æ··åç©ãšãããšåå¿ãåŸãå€
å®èœæ§ååç©ãšã®åå¿çæç©ã«æèç©è³ªãçµåã
ããéã«ãæèç©è³ªãåŸã ã«åå¿çæç©ããé¢ã
ãŠããããšãèŠåºãããã®çŸè±¡ãå°å°¿ã«ããŒãã«
ã«å¿çšããããšã«æå·§ããæ¬çºæã«å°éãããã®
ã§ããã
ããªãã¡æ¬çºæã¯ããªã¬ãã€ã³ç³»éåäœãŸãã¯
ãžãšã³ç³»éåäœãŸãã¯ã·ãªã³ã³ç³»éåäœãçŽ æãš
ããå°å°¿ã«ããŒãã«ã®å å£ãŸãã¯å€å£ã«ãããŠã
(A)ç¡æ°Žãã¬ã€ã³é žãšãããšå ±éåãåŸãè³éŠæã
ãã«ã¢ãããŒãŸãã¯ãªã¬ãã€ã³ã¢ãããŒãšã®å ±é
åäœã以äž(A)æåãšç¥èšãããã0.5ã99.5éééš
ãšã(B)ç¡æ°Žãã¬ã€ã³é žãšãããšå ±éåãåŸãèèª
æããã«ãšãŒãã«ãŸãã¯èèªæããã«ãšã¹ãã«ãš
ã®å ±éåäœã以äž(B)æåãšç¥èšãããã0.5ã99.5
éééšãšã(A)æåãš(B)æåã®åèšé100éééšã«
察ãïŒã200éééšã®(C)å€å®èœæ§ååç©ã以äž(C)
æåãšç¥èšãããããšãåå¿ãããŠã該å å£ãŸã
ã¯å€å£äžã«æªåå¿ã®ç¡æ°Žãã¬ã€ã³é žåºãæããç®
èã圢æããããã€ãã§è©²ç¡æ°Žãã¬ã€ã³é žåºã®äž
éšãŸãã¯å šéšãå æ°Žå解ããã®ã¡è©²ç®èã«æèç©
質ãçµåãããããšãç¹åŸŽãšããå°¿è·¯ææé²æ¢èœ
ãæããå°å°¿ã«ããŒãã«ã®è£œé æ¹æ³ã§ããã
ãžãšã³ç³»éåäœãŸãã¯ã·ãªã³ã³ç³»éåäœãçŽ æãš
ããå°å°¿ã«ããŒãã«ã®å å£ãŸãã¯å€å£ã«ãããŠã
(A)ç¡æ°Žãã¬ã€ã³é žãšãããšå ±éåãåŸãè³éŠæã
ãã«ã¢ãããŒãŸãã¯ãªã¬ãã€ã³ã¢ãããŒãšã®å ±é
åäœã以äž(A)æåãšç¥èšãããã0.5ã99.5éééš
ãšã(B)ç¡æ°Žãã¬ã€ã³é žãšãããšå ±éåãåŸãèèª
æããã«ãšãŒãã«ãŸãã¯èèªæããã«ãšã¹ãã«ãš
ã®å ±éåäœã以äž(B)æåãšç¥èšãããã0.5ã99.5
éééšãšã(A)æåãš(B)æåã®åèšé100éééšã«
察ãïŒã200éééšã®(C)å€å®èœæ§ååç©ã以äž(C)
æåãšç¥èšãããããšãåå¿ãããŠã該å å£ãŸã
ã¯å€å£äžã«æªåå¿ã®ç¡æ°Žãã¬ã€ã³é žåºãæããç®
èã圢æããããã€ãã§è©²ç¡æ°Žãã¬ã€ã³é žåºã®äž
éšãŸãã¯å šéšãå æ°Žå解ããã®ã¡è©²ç®èã«æèç©
質ãçµåãããããšãç¹åŸŽãšããå°¿è·¯ææé²æ¢èœ
ãæããå°å°¿ã«ããŒãã«ã®è£œé æ¹æ³ã§ããã
æ¬çºæã«ãããªã¬ãã€ã³ç³»éåäœãšã¯ãïŒåã®
äºéçµåãæããçåæ°ŽçŽ ãäŸãã°ãšãã¬ã³ãã
ããã¬ã³ãïŒâããã³ãïŒâã¡ãã«âïŒâãã
ã³ãïŒïŒïŒâãžã¡ãã«âïŒâããã³ãïŒâãã³ã
ã³ãïŒâã¡ãã«âïŒâãã³ãã³ãïŒâã¡ãã«âïŒ
âãã³ãã³ãïŒâããã»ã³ãïŒâã¡ãã«âïŒâã
ãã»ã³ãïŒâã¡ãã«âïŒâããã»ã³ãïŒâããã
ã³ãïŒâãªã¯ãã³ãïŒâãã»ã³ãïŒâãããµãã»
ã³ãïŒâãªã¯ã¿ãã»ã³ãããã«ã·ã¯ããããã³ã
ããã«ã·ã¯ããããµã³ãã€ãœããã¬ã³ãïŒâã¡ã
ã«âïŒâãã³ãã³ãã·ã¯ãããã³ããã«ãã«ãã³
ãªã©ãå ¬ç¥ã®æ¹æ³ã§åç¬ãããã¯å ±éåãããã
ã®ãããã
äºéçµåãæããçåæ°ŽçŽ ãäŸãã°ãšãã¬ã³ãã
ããã¬ã³ãïŒâããã³ãïŒâã¡ãã«âïŒâãã
ã³ãïŒïŒïŒâãžã¡ãã«âïŒâããã³ãïŒâãã³ã
ã³ãïŒâã¡ãã«âïŒâãã³ãã³ãïŒâã¡ãã«âïŒ
âãã³ãã³ãïŒâããã»ã³ãïŒâã¡ãã«âïŒâã
ãã»ã³ãïŒâã¡ãã«âïŒâããã»ã³ãïŒâããã
ã³ãïŒâãªã¯ãã³ãïŒâãã»ã³ãïŒâãããµãã»
ã³ãïŒâãªã¯ã¿ãã»ã³ãããã«ã·ã¯ããããã³ã
ããã«ã·ã¯ããããµã³ãã€ãœããã¬ã³ãïŒâã¡ã
ã«âïŒâãã³ãã³ãã·ã¯ãããã³ããã«ãã«ãã³
ãªã©ãå ¬ç¥ã®æ¹æ³ã§åç¬ãããã¯å ±éåãããã
ã®ãããã
æ¬çºæã«ãããžãšã³ç³»éåäœãšã¯ãäºéçµåã
ïŒåæããçåæ°ŽçŽ ãäŸãã°ãã¿ãžãšã³ãã€ãœã
ã¬ã³ãïŒïŒïŒâãã³ã¿ãžãšã³ãïŒïŒïŒâãããµãž
ãšã³ãïŒïŒïŒâããã¿ãžãšã³ãªã©ãå ¬ç¥ã®æ¹æ³ã§
åç¬ãããã¯å ±éåããããã®ããããäŸå€ãšã
ãŠã€ãœãã¬ã³ã®ã·ã¹âïŒïŒïŒâéåäœã¯å€©ç¶ãŽã
ãšããŠå€©ç¶ã«åºãååšãããããã®ãã®ãæ¬çºæ
ã«ãããŠå¥œãŸããå©çšãããã
ïŒåæããçåæ°ŽçŽ ãäŸãã°ãã¿ãžãšã³ãã€ãœã
ã¬ã³ãïŒïŒïŒâãã³ã¿ãžãšã³ãïŒïŒïŒâãããµãž
ãšã³ãïŒïŒïŒâããã¿ãžãšã³ãªã©ãå ¬ç¥ã®æ¹æ³ã§
åç¬ãããã¯å ±éåããããã®ããããäŸå€ãšã
ãŠã€ãœãã¬ã³ã®ã·ã¹âïŒïŒïŒâéåäœã¯å€©ç¶ãŽã
ãšããŠå€©ç¶ã«åºãååšãããããã®ãã®ãæ¬çºæ
ã«ãããŠå¥œãŸããå©çšãããã
å
±éåæåãšããŠã¯ãä»ã«ãäŸãã°é
¢é
žãã
ã«ãã¡ãã«ããã«ãšãŒãã«ãã¹ãã¬ã³ãå¡©åãã
ã«ãå¡©åãããªãã³ãç¡æ°Žãã¬ã€ã³é žãã¢ã¯ãªã«
é žãã¡ã¿ã¯ãªã«é žãã¢ã¯ãªããããªã«ãã¡ã¿ã¯ãª
ã«é žã¡ãã«ãäºé žåã€ãªãŠãããã«ããªãžã³ãã¯
ãããã¬ã³ããšãã¬ã³ãªãã·ãããã«ã ã¢ã«ãã
ããªã©ããããããã
ã«ãã¡ãã«ããã«ãšãŒãã«ãã¹ãã¬ã³ãå¡©åãã
ã«ãå¡©åãããªãã³ãç¡æ°Žãã¬ã€ã³é žãã¢ã¯ãªã«
é žãã¡ã¿ã¯ãªã«é žãã¢ã¯ãªããããªã«ãã¡ã¿ã¯ãª
ã«é žã¡ãã«ãäºé žåã€ãªãŠãããã«ããªãžã³ãã¯
ãããã¬ã³ããšãã¬ã³ãªãã·ãããã«ã ã¢ã«ãã
ããªã©ããããããã
æ¬çºæã«ããã·ãªã³ã³ç³»éåäœãšããŠã¯ãäŸã
ã°ãžã¡ãã«ããªã·ãããµã³ãã¡ãã«ããšãã«ããª
ã·ãããµã³ãã·ã¢ãã¢ã«ãã«ã¡ãã«ããªã·ãããµ
ã³ããããã¢ã«ãã«ã¡ãã«ã·ãããµã³ãªã©ããã
ããããããã®é«åŒŸåæ§ãé«åŒ·åºŠã人äœç¡å®³æ§ãª
ã©ã®é¢ãããžã¡ãã«ããªã·ãããµã³ããšãã«å¥œãŸ
ããã
ã°ãžã¡ãã«ããªã·ãããµã³ãã¡ãã«ããšãã«ããª
ã·ãããµã³ãã·ã¢ãã¢ã«ãã«ã¡ãã«ããªã·ãããµ
ã³ããããã¢ã«ãã«ã¡ãã«ã·ãããµã³ãªã©ããã
ããããããã®é«åŒŸåæ§ãé«åŒ·åºŠã人äœç¡å®³æ§ãª
ã©ã®é¢ãããžã¡ãã«ããªã·ãããµã³ããšãã«å¥œãŸ
ããã
æ¬çºæã«çšãã(A)æåãšããŠã¯ç¡æ°Žãã¬ã€ã³é
ž
ãšãããšå ±éåãåŸãè³éŠæããã«ã¢ãããŒãŸã
ã¯ãªã¬ãã€ã³ã¢ãããŒãšã®å ±éåäœã§ããã°ãã
ãªãå ±éåäœã§ã䜿çšå¯èœã§ãããã奜ãŸããã¯
ç¡æ°Žãã¬ã€ã³é žãšã¹ãã¬ã³ãŸãã¯ãšãã¬ã³ãŸãã¯
ã€ãœããã¬ã³ãŸãã¯ããªãããã¬ã³ãšã®å ±éåäœ
ã䜿çšãããç¹ã«å¥œãŸããã¯ç¡æ°Žãã¬ã€ã³é žãšäž
èšã®ã¢ãããŒãšã®å ±éåäœã§ãå ±éåæ¯ãïŒïŒïŒ
ãïŒïŒïŒã§ããååéã500ã2000000ã®ãã®ã䜿
çšãããã
ãšãããšå ±éåãåŸãè³éŠæããã«ã¢ãããŒãŸã
ã¯ãªã¬ãã€ã³ã¢ãããŒãšã®å ±éåäœã§ããã°ãã
ãªãå ±éåäœã§ã䜿çšå¯èœã§ãããã奜ãŸããã¯
ç¡æ°Žãã¬ã€ã³é žãšã¹ãã¬ã³ãŸãã¯ãšãã¬ã³ãŸãã¯
ã€ãœããã¬ã³ãŸãã¯ããªãããã¬ã³ãšã®å ±éåäœ
ã䜿çšãããç¹ã«å¥œãŸããã¯ç¡æ°Žãã¬ã€ã³é žãšäž
èšã®ã¢ãããŒãšã®å ±éåäœã§ãå ±éåæ¯ãïŒïŒïŒ
ãïŒïŒïŒã§ããååéã500ã2000000ã®ãã®ã䜿
çšãããã
æ¬çºæã«çšãã(B)æåãšããŠã¯ãç¡æ°Žãã¬ã€ã³
é žãšãããšå ±éåãåŸãèèªæããã«ãšãŒãã«ãŸ
ãã¯èèªæããã«ãšã¹ãã«ãšã®å ±éåäœã§ããã°
ãããªãå ±éåäœã§ã䜿çšå¯èœã§ãããã奜ãŸã
ãã¯ç¡æ°Žãã¬ã€ã³é žãšé ¢é žããã«ãŸãã¯ã¡ãã«ã
ãã«ãšãŒãã«ãŸãã¯ãšãã«ããã«ãšãŒãã«ãŸãã¯
ãã¿ã³ãžãªãŒã«ããã«ãšãŒãã«ãšã®å ±éåäœã䜿
çšãããç¹ã«å¥œãŸããã¯ç¡æ°Žãã¬ã€ã³é žãšäžèšã®
ã¢ãããŒãšã®å ±éåäœã§ãå ±éåæ¯ãïŒïŒïŒã
ïŒïŒïŒã§ããååéã500ã2000000ã®ãã®ã䜿çš
ããããæ¬çºæã«çšãã(C)æåãšããŠã¯ãäŸãã°
ãããµã¡ãã¬ã³ãžã€ãœã·ã¢ããŒãããã«ãšã³ãžã€
ãœã·ã¢ããŒãããã·ã¬ã³ãžã€ãœã·ã¢ããŒãããšã
ã¬ã³ãžã€ãœã·ã¢ããŒããã¢ããªã³âãã«ã ã¢ã«ã
ããã®ã€ãœã·ã¢ããŒãèªå°äœãªã©ã®ããªã€ãœã·ã¢
ããŒãããããµã¡ãã¬ã³ããªã€ãœã·ã¢ããŒããªã©
ã®ããªããªã€ãœã·ã¢ããŒããããã©ã¡ãã¬ã³ã°ãª
ã³ãŒã«ãã°ãªã·ãžã«ãšãŒãã«ããžãšãã¬ã³ã°ãªã³
ãŒã«ã®ãžã°ãªã·ãžã«ãšãŒãã«ãªã©ã®ããªãšããã·
ããããªããã«ã¢ã«ã³ãŒã«ãããªããã«ã¢ã«ã³ãŒ
ã«ãšãšãã¬ã³ããããã¬ã³ãå¡©åããã«ãã¢ãªã«
ã¢ã«ã³ãŒã«ãâããã«ãããªãã³ãªã©ãšã®å ±é
åäœãããªããã«ã¢ã«ã³ãŒã«ã®ã¡ãã«ããšãã«ã
ãããã«ãããã«ããªã¯ãã«ãããã·ã«ãããšã
ã«ãªã©ã®ãšãŒãã«èªå°äœãããªããã«ã¢ã«ã³ãŒã«
ã®ãã«ããŒã«ããšã¿ããŒã«ãããã©ãŒã«ãã¢ãã
ã¢ã»ã¿ãŒã«ãªã©ã®ã¢ã»ã¿ãŒã«èªå°äœãããªããã«
ã¢ã«ã³ãŒã«ã®é ¢é žãã®é žãé ªé žãã«ããã³é žãã©
ãŠãªã³é žãã¹ãã¢ãªã³é žãå®æ¯éŠé žãªã©ã®ãšã¹ã
ã«èªå°äœããšãã¬ã³ã°ãªã³ãŒã«ããããã¬ã³ã°ãª
ã³ãŒã«ãããã¬ã³ã°ãªã³ãŒã«ããžãšãã¬ã³ã°ãªã³
ãŒã«ãã·ã¯ããããµã³ãžãªãŒã«ããã³ã¿ãšãªã¹ãª
ããŒã«ãã°ãªã»ãªã³ãïŒïŒïŒïŒïŒâããªã¡ãããŒ
ã«ãããã³ãªã©ã®ããªãªãŒã«ããã³ãã®ã«ã«ãã
ã·ã¡ãã«åç©ãããªãšãã¬ã³ã°ãªã³ãŒã«ãããªã
ããã¬ã³ã°ãªã³ãŒã«ãããªããã©ã¡ãã¬ã³ã°ãªã³
ãŒã«ãããªãšãã¬ã³âããªãããã¬ã³ã°ãªã³ãŒã«
ãªã©ã®ããªãšãŒãã«ããªãªãŒã«ããã³ãã®ã«ã«ã
ãã·ã¡ãã«åç©ãã³ãã¯é žãã°ã«ã¿ã«é žãã¢ãžã
ã³é žãã»ãã·ã³é žãã€ãœãã¿ã«é žããã¿ã«é žãã
ã¬ãã¿ã«é žãªã©ã®ãžã«ã«ãã³é žãšãšãã¬ã³ã°ãªã³
ãŒã«ããããã¬ã³ã°ãªã³ãŒã«ãããã¬ã³ã°ãªã³ãŒ
ã«ãªã©ã®ã°ãªã³ãŒã«ãšã®çž®åã«ãã€ãŠåŸãããäž¡
æ«ç«¯ã«æ°Žé žåºãæããããªãšã¹ãã«ããã³ãã®ã«
ã«ããã·ã¡ãã«åç©ãã§ãã·ãããŒã©ãã³ããã
ã¹ãã©ã³ãªã©ã®å€©ç¶é«ååããã³ãã®ã«ã«ããã·
ã¡ãã«åç©ãã¢ããšã¿ããŒã«ã¢ãã³ãããªãšã¿ã
ãŒã«ã¢ãã³ãªã©ã®ã¢ããã¢ã«ã³ãŒã«ããã³ããªã¢
ãã³ãªã©ãããããããããªã¢ãã³ãšããŠã¯ãäŸ
ãã°äœååããªã¢ãã³ãšããŠãšãã¬ã³ãžã¢ãã³ã
ããªã¡ãã¬ã³ãžã¢ãã³ãïŒïŒïŒâãžã¢ããããã
ã³ãããã©ã¡ãã¬ã³ãžã¢ãã³ãïŒïŒïŒâãžã¢ãã
ãã¿ã³ãïŒïŒïŒâãžã¢ãããã¿ã³ããã³ã¿ã¡ãã¬
ã³ãžã¢ãã³ãïŒïŒïŒâãžã¢ãããã³ã¿ã³ããããµ
ã¡ãã¬ã³ãžã¢ãã³ããªã¯ã¿ã¡ãã¬ã³ãžã¢ãã³ãã
ãã¡ãã¬ã³ãžã¢ãã³ããã«ã¡ãã¬ã³ãžã¢ãã³ããŠ
ã³ãã«ã¡ãã¬ã³ãžã¢ãã³ãããã«ã¡ãã¬ã³ãžã¢ã
ã³ãããªãã«ã¡ãã¬ã³ãžã¢ãã³ããªã¯ã¿ãã«ã¡ã
ã¬ã³ãžã¢ãã³ãïŒïŒ®âãžã¡ãã«ãšãã¬ã³ãžã¢ã
ã³ãïŒïŒ®âãžãšãã«ããªã¡ãã¬ã³ãžã¢ãã³ã
ïŒïŒ®âãžã¡ãã«ããªã¡ãã¬ã³ãžã¢ãã³ãïŒïŒ®
âãžããã«ãã¡ãã¬ã³ãžã¢ãã³ãïŒïŒ®ïŒNâ²â
ããªãšãã«ãšãã¬ã³ãžã¢ãã³ãâã¡ãã«ããªã¡
ãã¬ã³ãžã¢ãã³ãïŒïŒ®âãžã¡ãã«âïœâããšã
ã¬ã³ãžã¢ãã³ãïŒïŒ®âãžã¡ãã«ãããµã¡ãã¬ã³
ãžã¢ãã³ããžãšãã¬ã³ããªã¢ãã³ãããªãšãã¬ã³
ããã©ãã³ãããã©ãšãã¬ã³ãã³ã¿ãã³ãããã¿
ãšãã¬ã³ãªã¯ã¿ãã³ããããšãã¬ã³ãã«ãã³ã
ïŒïŒïŒâãã¹ïŒ2â²âã¢ãããšãã«ã¢ããïŒããã
ã³ããã¹ïŒïŒâã¢ãããããã«ïŒã¢ãã³ãïŒïŒïŒ
âãã¹ïŒ3â²âã¢ãããããã«ã¢ããïŒãããã³ã
ïŒïŒïŒïŒïŒïŒâããªã¢ãããããã³ãããªã¹ïŒïŒ
âã¢ãããšãã«ïŒã¢ãã³ãããã©ïŒã¢ããã¡ã
ã«ïŒã¡ã¿ã³ãã¡ãã«ã€ãããã¹ãããã«ã¢ãã³ã
ã¡ãã«ã€ãããã¹ãšãã«ã¢ãã³ããšãã«ã€ããã
ã¹ãšãã«ã¢ãã³ãâã¢ãããããã«âïŒã¢ã«ã
ãªã³ãâã¢ãããããã«âïŒâããã³ãªã³ã
âïŒïŒâããããã·ãšãã«ïŒããªã¡ãã¬ã³ãžã¢ã
ã³ããã·ãªã¬ã³ãžã¢ãã³ãããšãã¬ã³ãžã¢ãã³ã
ããã©ãžã³ãâã¡ãã«ããã©ãžã³ãâïŒïŒâ
ã¢ãããšãã«ïŒãšã¿ããŒã«ã¢ãã³ãâã¢ãããš
ãã«ããã©ãžã³ãïŒïŒ®ïŒNâ²ïŒNâ²âããã©ã¡ã
ã«ãšãã¬ã³ãžã¢ãã³ãïŒïŒ®ïŒNâ²ïŒNâ²âããã©
ã¡ãã«ããã©ã¡ãã¬ã³ãžã¢ãã³ãªã©ãããããã
é«ååããªã¢ãã³ãšããŠ(i)ã¢ãã³ãšã¢ã«ãã¬ã³ãž
ãã©ã€ããããã¯ãšãã¯ãã«ãããªã³ããåæã
ããããªïŒã¢ã«ãã¬ã³ããªã¢ãã³ïŒããšã³ãµã€ã¯
ãããã€ã¢ïŒãªãã»ããªããŒã»ãµã€ãšã³ã¹ã»ã¢ã³
ãã»ãã¯ãããžãŒãïŒEncyclopedia of Polymer
Science and TechnologyïŒ10å·»ã616é ãã(ii)ãš
ãã¬ã³ã€ãã³ããããã¬ã³ã€ãã³ãªã©ã®ã¢ã«ãã¬
ã³ã€ãã³ã®éç°éåã«ãã€ãŠåŸãããã¢ã«ãã¬ã³
ã€ãã³éåäœããšã³ãµã€ã¯ãããã€ã¢ã»ãªãã»ã
ãªããŒã»ãµã€ãšã³ã¹ã»ã¢ã³ãã»ãã¯ãããžãŒãïŒ
å·»ã734é ãã(iii)ãã®ä»ããªããã«ã¢ãã³ãããªãª
ãžã³ãªã©ãããããããããããã®ãªãã§ã¯çäœ
é©åæ§ãç¡æ¯æ§ãªã©ã®èŠ³ç¹ããããããªããã«ã¢
ã«ã³ãŒã«ãšãã®èªå°äœãããªãªãŒã«ãããªãšãŒã
ã«ããªãªãŒã«ã奜ãŸããçšããããã
é žãšãããšå ±éåãåŸãèèªæããã«ãšãŒãã«ãŸ
ãã¯èèªæããã«ãšã¹ãã«ãšã®å ±éåäœã§ããã°
ãããªãå ±éåäœã§ã䜿çšå¯èœã§ãããã奜ãŸã
ãã¯ç¡æ°Žãã¬ã€ã³é žãšé ¢é žããã«ãŸãã¯ã¡ãã«ã
ãã«ãšãŒãã«ãŸãã¯ãšãã«ããã«ãšãŒãã«ãŸãã¯
ãã¿ã³ãžãªãŒã«ããã«ãšãŒãã«ãšã®å ±éåäœã䜿
çšãããç¹ã«å¥œãŸããã¯ç¡æ°Žãã¬ã€ã³é žãšäžèšã®
ã¢ãããŒãšã®å ±éåäœã§ãå ±éåæ¯ãïŒïŒïŒã
ïŒïŒïŒã§ããååéã500ã2000000ã®ãã®ã䜿çš
ããããæ¬çºæã«çšãã(C)æåãšããŠã¯ãäŸãã°
ãããµã¡ãã¬ã³ãžã€ãœã·ã¢ããŒãããã«ãšã³ãžã€
ãœã·ã¢ããŒãããã·ã¬ã³ãžã€ãœã·ã¢ããŒãããšã
ã¬ã³ãžã€ãœã·ã¢ããŒããã¢ããªã³âãã«ã ã¢ã«ã
ããã®ã€ãœã·ã¢ããŒãèªå°äœãªã©ã®ããªã€ãœã·ã¢
ããŒãããããµã¡ãã¬ã³ããªã€ãœã·ã¢ããŒããªã©
ã®ããªããªã€ãœã·ã¢ããŒããããã©ã¡ãã¬ã³ã°ãª
ã³ãŒã«ãã°ãªã·ãžã«ãšãŒãã«ããžãšãã¬ã³ã°ãªã³
ãŒã«ã®ãžã°ãªã·ãžã«ãšãŒãã«ãªã©ã®ããªãšããã·
ããããªããã«ã¢ã«ã³ãŒã«ãããªããã«ã¢ã«ã³ãŒ
ã«ãšãšãã¬ã³ããããã¬ã³ãå¡©åããã«ãã¢ãªã«
ã¢ã«ã³ãŒã«ãâããã«ãããªãã³ãªã©ãšã®å ±é
åäœãããªããã«ã¢ã«ã³ãŒã«ã®ã¡ãã«ããšãã«ã
ãããã«ãããã«ããªã¯ãã«ãããã·ã«ãããšã
ã«ãªã©ã®ãšãŒãã«èªå°äœãããªããã«ã¢ã«ã³ãŒã«
ã®ãã«ããŒã«ããšã¿ããŒã«ãããã©ãŒã«ãã¢ãã
ã¢ã»ã¿ãŒã«ãªã©ã®ã¢ã»ã¿ãŒã«èªå°äœãããªããã«
ã¢ã«ã³ãŒã«ã®é ¢é žãã®é žãé ªé žãã«ããã³é žãã©
ãŠãªã³é žãã¹ãã¢ãªã³é žãå®æ¯éŠé žãªã©ã®ãšã¹ã
ã«èªå°äœããšãã¬ã³ã°ãªã³ãŒã«ããããã¬ã³ã°ãª
ã³ãŒã«ãããã¬ã³ã°ãªã³ãŒã«ããžãšãã¬ã³ã°ãªã³
ãŒã«ãã·ã¯ããããµã³ãžãªãŒã«ããã³ã¿ãšãªã¹ãª
ããŒã«ãã°ãªã»ãªã³ãïŒïŒïŒïŒïŒâããªã¡ãããŒ
ã«ãããã³ãªã©ã®ããªãªãŒã«ããã³ãã®ã«ã«ãã
ã·ã¡ãã«åç©ãããªãšãã¬ã³ã°ãªã³ãŒã«ãããªã
ããã¬ã³ã°ãªã³ãŒã«ãããªããã©ã¡ãã¬ã³ã°ãªã³
ãŒã«ãããªãšãã¬ã³âããªãããã¬ã³ã°ãªã³ãŒã«
ãªã©ã®ããªãšãŒãã«ããªãªãŒã«ããã³ãã®ã«ã«ã
ãã·ã¡ãã«åç©ãã³ãã¯é žãã°ã«ã¿ã«é žãã¢ãžã
ã³é žãã»ãã·ã³é žãã€ãœãã¿ã«é žããã¿ã«é žãã
ã¬ãã¿ã«é žãªã©ã®ãžã«ã«ãã³é žãšãšãã¬ã³ã°ãªã³
ãŒã«ããããã¬ã³ã°ãªã³ãŒã«ãããã¬ã³ã°ãªã³ãŒ
ã«ãªã©ã®ã°ãªã³ãŒã«ãšã®çž®åã«ãã€ãŠåŸãããäž¡
æ«ç«¯ã«æ°Žé žåºãæããããªãšã¹ãã«ããã³ãã®ã«
ã«ããã·ã¡ãã«åç©ãã§ãã·ãããŒã©ãã³ããã
ã¹ãã©ã³ãªã©ã®å€©ç¶é«ååããã³ãã®ã«ã«ããã·
ã¡ãã«åç©ãã¢ããšã¿ããŒã«ã¢ãã³ãããªãšã¿ã
ãŒã«ã¢ãã³ãªã©ã®ã¢ããã¢ã«ã³ãŒã«ããã³ããªã¢
ãã³ãªã©ãããããããããªã¢ãã³ãšããŠã¯ãäŸ
ãã°äœååããªã¢ãã³ãšããŠãšãã¬ã³ãžã¢ãã³ã
ããªã¡ãã¬ã³ãžã¢ãã³ãïŒïŒïŒâãžã¢ããããã
ã³ãããã©ã¡ãã¬ã³ãžã¢ãã³ãïŒïŒïŒâãžã¢ãã
ãã¿ã³ãïŒïŒïŒâãžã¢ãããã¿ã³ããã³ã¿ã¡ãã¬
ã³ãžã¢ãã³ãïŒïŒïŒâãžã¢ãããã³ã¿ã³ããããµ
ã¡ãã¬ã³ãžã¢ãã³ããªã¯ã¿ã¡ãã¬ã³ãžã¢ãã³ãã
ãã¡ãã¬ã³ãžã¢ãã³ããã«ã¡ãã¬ã³ãžã¢ãã³ããŠ
ã³ãã«ã¡ãã¬ã³ãžã¢ãã³ãããã«ã¡ãã¬ã³ãžã¢ã
ã³ãããªãã«ã¡ãã¬ã³ãžã¢ãã³ããªã¯ã¿ãã«ã¡ã
ã¬ã³ãžã¢ãã³ãïŒïŒ®âãžã¡ãã«ãšãã¬ã³ãžã¢ã
ã³ãïŒïŒ®âãžãšãã«ããªã¡ãã¬ã³ãžã¢ãã³ã
ïŒïŒ®âãžã¡ãã«ããªã¡ãã¬ã³ãžã¢ãã³ãïŒïŒ®
âãžããã«ãã¡ãã¬ã³ãžã¢ãã³ãïŒïŒ®ïŒNâ²â
ããªãšãã«ãšãã¬ã³ãžã¢ãã³ãâã¡ãã«ããªã¡
ãã¬ã³ãžã¢ãã³ãïŒïŒ®âãžã¡ãã«âïœâããšã
ã¬ã³ãžã¢ãã³ãïŒïŒ®âãžã¡ãã«ãããµã¡ãã¬ã³
ãžã¢ãã³ããžãšãã¬ã³ããªã¢ãã³ãããªãšãã¬ã³
ããã©ãã³ãããã©ãšãã¬ã³ãã³ã¿ãã³ãããã¿
ãšãã¬ã³ãªã¯ã¿ãã³ããããšãã¬ã³ãã«ãã³ã
ïŒïŒïŒâãã¹ïŒ2â²âã¢ãããšãã«ã¢ããïŒããã
ã³ããã¹ïŒïŒâã¢ãããããã«ïŒã¢ãã³ãïŒïŒïŒ
âãã¹ïŒ3â²âã¢ãããããã«ã¢ããïŒãããã³ã
ïŒïŒïŒïŒïŒïŒâããªã¢ãããããã³ãããªã¹ïŒïŒ
âã¢ãããšãã«ïŒã¢ãã³ãããã©ïŒã¢ããã¡ã
ã«ïŒã¡ã¿ã³ãã¡ãã«ã€ãããã¹ãããã«ã¢ãã³ã
ã¡ãã«ã€ãããã¹ãšãã«ã¢ãã³ããšãã«ã€ããã
ã¹ãšãã«ã¢ãã³ãâã¢ãããããã«âïŒã¢ã«ã
ãªã³ãâã¢ãããããã«âïŒâããã³ãªã³ã
âïŒïŒâããããã·ãšãã«ïŒããªã¡ãã¬ã³ãžã¢ã
ã³ããã·ãªã¬ã³ãžã¢ãã³ãããšãã¬ã³ãžã¢ãã³ã
ããã©ãžã³ãâã¡ãã«ããã©ãžã³ãâïŒïŒâ
ã¢ãããšãã«ïŒãšã¿ããŒã«ã¢ãã³ãâã¢ãããš
ãã«ããã©ãžã³ãïŒïŒ®ïŒNâ²ïŒNâ²âããã©ã¡ã
ã«ãšãã¬ã³ãžã¢ãã³ãïŒïŒ®ïŒNâ²ïŒNâ²âããã©
ã¡ãã«ããã©ã¡ãã¬ã³ãžã¢ãã³ãªã©ãããããã
é«ååããªã¢ãã³ãšããŠ(i)ã¢ãã³ãšã¢ã«ãã¬ã³ãž
ãã©ã€ããããã¯ãšãã¯ãã«ãããªã³ããåæã
ããããªïŒã¢ã«ãã¬ã³ããªã¢ãã³ïŒããšã³ãµã€ã¯
ãããã€ã¢ïŒãªãã»ããªããŒã»ãµã€ãšã³ã¹ã»ã¢ã³
ãã»ãã¯ãããžãŒãïŒEncyclopedia of Polymer
Science and TechnologyïŒ10å·»ã616é ãã(ii)ãš
ãã¬ã³ã€ãã³ããããã¬ã³ã€ãã³ãªã©ã®ã¢ã«ãã¬
ã³ã€ãã³ã®éç°éåã«ãã€ãŠåŸãããã¢ã«ãã¬ã³
ã€ãã³éåäœããšã³ãµã€ã¯ãããã€ã¢ã»ãªãã»ã
ãªããŒã»ãµã€ãšã³ã¹ã»ã¢ã³ãã»ãã¯ãããžãŒãïŒ
å·»ã734é ãã(iii)ãã®ä»ããªããã«ã¢ãã³ãããªãª
ãžã³ãªã©ãããããããããããã®ãªãã§ã¯çäœ
é©åæ§ãç¡æ¯æ§ãªã©ã®èŠ³ç¹ããããããªããã«ã¢
ã«ã³ãŒã«ãšãã®èªå°äœãããªãªãŒã«ãããªãšãŒã
ã«ããªãªãŒã«ã奜ãŸããçšããããã
æ¬çºæã«ããæèç©è³ªãšã¯ãæçç©è³ªããã³æ®º
èå€ã®ããšããããæçç©è³ªãšããŠã¯äŸãã°ã¯ã
ããµã·ãªã³ããžã¯ãããµã·ãªã³ããã«ã¯ãããµã·
ãªã³ãã¢ã³ãã·ãªã³ããã¿ã·ãªã³ãã¿ã©ã³ãã·ãª
ã³ãã·ã¯ã©ã·ãªã³ãã¢ã¢ãã·ã·ãªã³ãããã¡ã·ãª
ãã ãããã©ã·ãªã³ãªã©ã®ããã·ãªã³é¡ãã»ãã¢
ããªãžã³ãã»ãã¢ãã°ãªã·ã³ãã»ãã¢ã¬ãã·ã³ã
ã»ãã¢ãŸãªã³ãã»ãã¢ããªã³ãã»ãã©ãžã³ãã»ã
ããŸãŒã«ãã»ããªãã·ãã³ãã»ãã¢ããªãžã³ãªã©
ã®ã»ãã¢ãã¹ããªã³é¡ãã¹ãã¬ãããã€ã·ã³ãã«
ããã€ã·ã³ããã©ãžãªãã€ã·ã³ïŒããã¢ãã€ã·
ã³ãã²ã³ã¿ãã€ã·ã³ããã«ããã€ã·ã³ããªãã¹ã¿
ãã€ã·ã³ããžãã«ã·ã³ãã¢ãã«ã·ã³ãããã©ãã€
ã·ã³ãã¹ãã¯ãããã€ã·ã³ãªã©ã®ã¢ããã°ãªã³ã·
ãé¡ããªãã·ããã©ãµã€ã¯ãªã³ãããã©ãµã€ã¯ãª
ã³ããã¡ãã«ã¯ãã«ããã©ãµã€ã¯ãªã³ãã¡ã¿ãµã€
ã¯ãªã³ãããã·ãµã€ã¯ãªã³ããããµã€ã¯ãªã³ãªã©
ã®ããã©ãµã€ã¯ãªã³é¡ããšãªã¹ããã€ã·ã³ããã¿
ãµãã€ã·ã³ããªã¬ã¢ã³ããã€ã·ã³ãã¹ãã©ãã€ã·
ã³ããžãšãµãã€ã·ã³ãããã«ãã€ã·ã³ãªã©ã®ãã¯
ãã©ã€ãé¡ããªã³ã³ãã€ã·ã³ãã¯ãªã³ããã€ã·ã³
ãªã©ã®ãªã³ã³ãã€ã·ã³é¡ããã«ãã€ã·ã³ãã°ã©ã
ã·ãžã³ïŒ³ãã°ã©ãã·ãžã³ãªã©ã®ã¢ã³ãã°ã©ã éœæ§
ãã¯ããªã¢é¡ãã³ãªã¹ãã³ãããªããã·ã³ïŒ¢ãªã©
ã®ããªããã·ã³é¡ããã€ãªãã€ã·ã³ãã«ãã¬ãªã
ã€ã·ã³ããšã³ããªãã€ã·ã³ããµã€ã¯ãã»ãªã³ãªã©
ã®ã¢ã³ããã³ãã¯ããªãŠã é¡ãã¢ã ãããªã·ã³
ããããªã·ã³ãªã©ã®ããªãšã³ãã¯ãã©ã€ãé¡ã
ãªãã¢ã³ãã·ã³ããããŒã«ãããªã³ããã€ããã€
ã·ã³ïŒ£ãã¢ã¯ãããã€ã·ã³ããã¬ãªãã€ã·ã³ãã
ãŠãã«ãã·ã³ããããœã«ãã·ã³ãããªã«ã«ããã¹
ã¿ãã³ãªã©ããããããããå¡©åºæ§ã®åŒ·ãç¹ãã
ã³å°¿è·¯ææçåå èã«å¯Ÿããå¹èåã倧ããç¹ã
ãã¢ããã°ãªã³ã·ãé¡ãŸãã¯ããªããã·ã³é¡ã奜
ãŸããçšããããã殺èå€ãšããŠã¯ã¢ã¯ãªããŒ
ã«ãã¢ã¯ãªã«ãã©ãã³ãªã©ã®è²çŽ 補å€ããããã
ã©ãŸã³ãªã©ã®ãã©ã³è£œå€ãå¡©åãã³ã¶ã«ã³ããŠ
ã ãå¡©åãã³ã¶ãããŠã ãªã©ã®éœæ§ç³ãã補å€ã
ã·ã¯ãããã·ãžã³ããããã³ãšãŒããªã©ã奜ãŸã
ãçšããããã
èå€ã®ããšããããæçç©è³ªãšããŠã¯äŸãã°ã¯ã
ããµã·ãªã³ããžã¯ãããµã·ãªã³ããã«ã¯ãããµã·
ãªã³ãã¢ã³ãã·ãªã³ããã¿ã·ãªã³ãã¿ã©ã³ãã·ãª
ã³ãã·ã¯ã©ã·ãªã³ãã¢ã¢ãã·ã·ãªã³ãããã¡ã·ãª
ãã ãããã©ã·ãªã³ãªã©ã®ããã·ãªã³é¡ãã»ãã¢
ããªãžã³ãã»ãã¢ãã°ãªã·ã³ãã»ãã¢ã¬ãã·ã³ã
ã»ãã¢ãŸãªã³ãã»ãã¢ããªã³ãã»ãã©ãžã³ãã»ã
ããŸãŒã«ãã»ããªãã·ãã³ãã»ãã¢ããªãžã³ãªã©
ã®ã»ãã¢ãã¹ããªã³é¡ãã¹ãã¬ãããã€ã·ã³ãã«
ããã€ã·ã³ããã©ãžãªãã€ã·ã³ïŒããã¢ãã€ã·
ã³ãã²ã³ã¿ãã€ã·ã³ããã«ããã€ã·ã³ããªãã¹ã¿
ãã€ã·ã³ããžãã«ã·ã³ãã¢ãã«ã·ã³ãããã©ãã€
ã·ã³ãã¹ãã¯ãããã€ã·ã³ãªã©ã®ã¢ããã°ãªã³ã·
ãé¡ããªãã·ããã©ãµã€ã¯ãªã³ãããã©ãµã€ã¯ãª
ã³ããã¡ãã«ã¯ãã«ããã©ãµã€ã¯ãªã³ãã¡ã¿ãµã€
ã¯ãªã³ãããã·ãµã€ã¯ãªã³ããããµã€ã¯ãªã³ãªã©
ã®ããã©ãµã€ã¯ãªã³é¡ããšãªã¹ããã€ã·ã³ããã¿
ãµãã€ã·ã³ããªã¬ã¢ã³ããã€ã·ã³ãã¹ãã©ãã€ã·
ã³ããžãšãµãã€ã·ã³ãããã«ãã€ã·ã³ãªã©ã®ãã¯
ãã©ã€ãé¡ããªã³ã³ãã€ã·ã³ãã¯ãªã³ããã€ã·ã³
ãªã©ã®ãªã³ã³ãã€ã·ã³é¡ããã«ãã€ã·ã³ãã°ã©ã
ã·ãžã³ïŒ³ãã°ã©ãã·ãžã³ãªã©ã®ã¢ã³ãã°ã©ã éœæ§
ãã¯ããªã¢é¡ãã³ãªã¹ãã³ãããªããã·ã³ïŒ¢ãªã©
ã®ããªããã·ã³é¡ããã€ãªãã€ã·ã³ãã«ãã¬ãªã
ã€ã·ã³ããšã³ããªãã€ã·ã³ããµã€ã¯ãã»ãªã³ãªã©
ã®ã¢ã³ããã³ãã¯ããªãŠã é¡ãã¢ã ãããªã·ã³
ããããªã·ã³ãªã©ã®ããªãšã³ãã¯ãã©ã€ãé¡ã
ãªãã¢ã³ãã·ã³ããããŒã«ãããªã³ããã€ããã€
ã·ã³ïŒ£ãã¢ã¯ãããã€ã·ã³ããã¬ãªãã€ã·ã³ãã
ãŠãã«ãã·ã³ããããœã«ãã·ã³ãããªã«ã«ããã¹
ã¿ãã³ãªã©ããããããããå¡©åºæ§ã®åŒ·ãç¹ãã
ã³å°¿è·¯ææçåå èã«å¯Ÿããå¹èåã倧ããç¹ã
ãã¢ããã°ãªã³ã·ãé¡ãŸãã¯ããªããã·ã³é¡ã奜
ãŸããçšããããã殺èå€ãšããŠã¯ã¢ã¯ãªããŒ
ã«ãã¢ã¯ãªã«ãã©ãã³ãªã©ã®è²çŽ 補å€ããããã
ã©ãŸã³ãªã©ã®ãã©ã³è£œå€ãå¡©åãã³ã¶ã«ã³ããŠ
ã ãå¡©åãã³ã¶ãããŠã ãªã©ã®éœæ§ç³ãã補å€ã
ã·ã¯ãããã·ãžã³ããããã³ãšãŒããªã©ã奜ãŸã
ãçšããããã
æ¬çºæã®æ¹æ³ã«ãã€ãŠå°å°¿ã«ããŒãã«ã補é ã
ãã«ã¯ããŸãã(A)æåãš(B)æåãš(C)æåãšãã«ã
ãŒãã«ã®å å£ãŸãã¯å€å£ã«ãããŠåå¿ãããŠãã®
å å£ãŸãã¯å€å£äžã«ç®èã圢æãããããšãå¿ èŠ
ã§ããããã®ããã«ã¯ãäŸãã°ææ©æº¶å€ãåªäœãš
ããŠ(A)æåãš(B)æåãš(C)æåãæ··åãããã®æº¶æ¶²
ã«ã«ããŒãã«ã®å å£ãŸãã¯å€å£ãæ¥è§Šãããã€ã
ã§ãã«ããŒãã«ãå ç±ããã°ãããäžæåãæ··å
ããæ¹æ³ãšããŠã¯ãäŸãã°(A)æåã®æº¶æ¶²ãš(B)æå
ã®æº¶æ¶²ãš(C)æåã®æº¶æ¶²ãæ··åããæ¹æ³ã(A)æåãš
(B)æåã«æº¶å€ãå ããŠåŸããã溶液ã«(C)æåãå
ããæ¹æ³ã(A)æåãš(B)æåãš(C)æåã®æ··åç©ã«æº¶
å€ãå ããæ¹æ³ãªã©ãã©ã®ãããªé åºãæ¹æ³ã§ã
å¯èœã§ãããæ··åå¹æãé«ãæ··åæéãçããã
ãããã«ã¯ãå¿ èŠã«å¿ããŠå ç±ããããæ¹æãã
ã®ãæãŸãããæ¬çºæã«äœ¿çšå¯èœãªææ©æº¶å€ãšã
ãŠã¯ãäŸãã°ã¢ã»ãã³ãã¡ãã«ãšãã«ã±ãã³ãªã©
ã®ã±ãã³é¡ããã³ãºã¢ã«ãããããã«ã ã¢ã«ãã
ãããžã¡ãã«ãã«ã ã¢ã«ããããªã©ã®ã¢ã«ããã
é¡ãããã©ããããã©ã³ãªã©ã®ãšãŒãã«é¡ãé ¢é ž
ã¡ãã«ãé ¢é žãšãã«ãªã©ã®ãšã¹ãã«é¡ãã¡ã¿ããŒ
ã«ããšã¿ããŒã«ããããããŒã«ãã€ãœãããããŒ
ã«ããã¿ããŒã«ãªã©ã®ã¢ã«ã³ãŒã«é¡ãªã©ãããã
ãããã奜ãŸããã¯ã±ãã³é¡ãã¢ã«ã³ãŒã«é¡ãçš
ããããããã®ããã«ããŠèª¿è£œãã溶液ãã«ããŒ
ãã«ã®å å£ãŸãã¯å€å£ã«æ¥è§Šãããã«ã¯ãããšã
ã°ã«ããŒãã«ã溶液ã«æµžæŒ¬ããããããã¯æº¶æ¶²ã
ã«ããŒãã«ã«åŽé§ããããããã¯ããšãã°ãã¯ã¿
ãŒãã€ãããã¯ãããªã©ãçšããŠå¡åžãããªã©ã®
æ¹æ³ãé©å®éžã¶ããšãã§ããããã®ããã«ã«ããŒ
ãã«ã«æº¶æ¶²ãæ¥è§ŠãããåŸã溶åªã也ç¥é€å»ãã
ã€ãã§å¥œãŸããã¯30ã180âããšãã«å¥œãŸããã¯
50ã160âã§å¥œãŸããã¯ïŒåã48æéããšãã«å¥œ
ãŸããã¯10åã24æéå ç±ããããšã«ãã(A)æå
ãš(B)æåãš(C)æåãšãåå¿ãããŠãã«ããŒãã«ã®
å å£ãŸãã¯å€å£äžã«ç®èã圢æããããããšãã§
ãããã«ããŒãã«ã®å å£ãŸãã¯å€å£ã«ãããŠåå¿
ããã(A)æåãš(B)æåãš(C)æåã®å²åã¯ã(A)æå
ã0.5ã99.5éééšã«å¯Ÿã(B)æåã¯0.5ã99.5éé
éšã§ããã(C)æåã¯(A)æåãš(B)æåã®åèšé100
éééšã«å¯ŸãïŒã200éééšã§ããã(A)æåãš(B)
æåã®åèšéã«å¯Ÿãã(A)æåã®å²åã0.5ééïŒ
æªæºã®å Žåã«ã¯åŸãããç®èã®å°¿ã«å¯Ÿãã溶解æ§
ã倧ããããã®ã§é·æéã®äœå ç眮äžã«ã¯ç®èã
溶解ããããäžæ¹ã99.5ééïŒ ããããå Žåã«ã¯
æèç©è³ªãçµåããèœåãèããæžå°ãããŸã被
è圢ææ§ãæªããªãã®ã§ã(A)æåã®å²åã¯0.5ã
99.5ééïŒ ã奜ãŸããã¯20ã99.5ééïŒ ãç¹ã«å¥œ
ãŸããã¯30ã95ééïŒ ã§ããããšãå¿ èŠã§ããã
(A)æåãš(B)æåã®åèšé100éééšã«å¯Ÿãã(C)æ
åã®å²åãïŒéééšæªæºã®å Žåã¯ã(A)æåãš(B)æ
åã®çš®é¡ãããã¯é åæ¯ã«ãã€ãŠã¯å°¿ã«å¯Ÿãã溶
解æ§ã倧ãããªããããããšããããäžæ¹ã200
éééšããããå Žåã¯ãåŸãããç®èã®æèç©è³ª
ãçµåããèœåãèããæžå°ããã®ã¿ã§ãªããç®
è圢ææ§ãæªããªãã®ã§ã(C)æåã®å²åã¯ïŒã
200éééšã奜ãŸããã¯ïŒã150éééšãç¹ã«å¥œãŸ
ããã¯ã20ã100éééšã§ããããšãå¿ èŠã§ããã
ãã«ã¯ããŸãã(A)æåãš(B)æåãš(C)æåãšãã«ã
ãŒãã«ã®å å£ãŸãã¯å€å£ã«ãããŠåå¿ãããŠãã®
å å£ãŸãã¯å€å£äžã«ç®èã圢æãããããšãå¿ èŠ
ã§ããããã®ããã«ã¯ãäŸãã°ææ©æº¶å€ãåªäœãš
ããŠ(A)æåãš(B)æåãš(C)æåãæ··åãããã®æº¶æ¶²
ã«ã«ããŒãã«ã®å å£ãŸãã¯å€å£ãæ¥è§Šãããã€ã
ã§ãã«ããŒãã«ãå ç±ããã°ãããäžæåãæ··å
ããæ¹æ³ãšããŠã¯ãäŸãã°(A)æåã®æº¶æ¶²ãš(B)æå
ã®æº¶æ¶²ãš(C)æåã®æº¶æ¶²ãæ··åããæ¹æ³ã(A)æåãš
(B)æåã«æº¶å€ãå ããŠåŸããã溶液ã«(C)æåãå
ããæ¹æ³ã(A)æåãš(B)æåãš(C)æåã®æ··åç©ã«æº¶
å€ãå ããæ¹æ³ãªã©ãã©ã®ãããªé åºãæ¹æ³ã§ã
å¯èœã§ãããæ··åå¹æãé«ãæ··åæéãçããã
ãããã«ã¯ãå¿ èŠã«å¿ããŠå ç±ããããæ¹æãã
ã®ãæãŸãããæ¬çºæã«äœ¿çšå¯èœãªææ©æº¶å€ãšã
ãŠã¯ãäŸãã°ã¢ã»ãã³ãã¡ãã«ãšãã«ã±ãã³ãªã©
ã®ã±ãã³é¡ããã³ãºã¢ã«ãããããã«ã ã¢ã«ãã
ãããžã¡ãã«ãã«ã ã¢ã«ããããªã©ã®ã¢ã«ããã
é¡ãããã©ããããã©ã³ãªã©ã®ãšãŒãã«é¡ãé ¢é ž
ã¡ãã«ãé ¢é žãšãã«ãªã©ã®ãšã¹ãã«é¡ãã¡ã¿ããŒ
ã«ããšã¿ããŒã«ããããããŒã«ãã€ãœãããããŒ
ã«ããã¿ããŒã«ãªã©ã®ã¢ã«ã³ãŒã«é¡ãªã©ãããã
ãããã奜ãŸããã¯ã±ãã³é¡ãã¢ã«ã³ãŒã«é¡ãçš
ããããããã®ããã«ããŠèª¿è£œãã溶液ãã«ããŒ
ãã«ã®å å£ãŸãã¯å€å£ã«æ¥è§Šãããã«ã¯ãããšã
ã°ã«ããŒãã«ã溶液ã«æµžæŒ¬ããããããã¯æº¶æ¶²ã
ã«ããŒãã«ã«åŽé§ããããããã¯ããšãã°ãã¯ã¿
ãŒãã€ãããã¯ãããªã©ãçšããŠå¡åžãããªã©ã®
æ¹æ³ãé©å®éžã¶ããšãã§ããããã®ããã«ã«ããŒ
ãã«ã«æº¶æ¶²ãæ¥è§ŠãããåŸã溶åªã也ç¥é€å»ãã
ã€ãã§å¥œãŸããã¯30ã180âããšãã«å¥œãŸããã¯
50ã160âã§å¥œãŸããã¯ïŒåã48æéããšãã«å¥œ
ãŸããã¯10åã24æéå ç±ããããšã«ãã(A)æå
ãš(B)æåãš(C)æåãšãåå¿ãããŠãã«ããŒãã«ã®
å å£ãŸãã¯å€å£äžã«ç®èã圢æããããããšãã§
ãããã«ããŒãã«ã®å å£ãŸãã¯å€å£ã«ãããŠåå¿
ããã(A)æåãš(B)æåãš(C)æåã®å²åã¯ã(A)æå
ã0.5ã99.5éééšã«å¯Ÿã(B)æåã¯0.5ã99.5éé
éšã§ããã(C)æåã¯(A)æåãš(B)æåã®åèšé100
éééšã«å¯ŸãïŒã200éééšã§ããã(A)æåãš(B)
æåã®åèšéã«å¯Ÿãã(A)æåã®å²åã0.5ééïŒ
æªæºã®å Žåã«ã¯åŸãããç®èã®å°¿ã«å¯Ÿãã溶解æ§
ã倧ããããã®ã§é·æéã®äœå ç眮äžã«ã¯ç®èã
溶解ããããäžæ¹ã99.5ééïŒ ããããå Žåã«ã¯
æèç©è³ªãçµåããèœåãèããæžå°ãããŸã被
è圢ææ§ãæªããªãã®ã§ã(A)æåã®å²åã¯0.5ã
99.5ééïŒ ã奜ãŸããã¯20ã99.5ééïŒ ãç¹ã«å¥œ
ãŸããã¯30ã95ééïŒ ã§ããããšãå¿ èŠã§ããã
(A)æåãš(B)æåã®åèšé100éééšã«å¯Ÿãã(C)æ
åã®å²åãïŒéééšæªæºã®å Žåã¯ã(A)æåãš(B)æ
åã®çš®é¡ãããã¯é åæ¯ã«ãã€ãŠã¯å°¿ã«å¯Ÿãã溶
解æ§ã倧ãããªããããããšããããäžæ¹ã200
éééšããããå Žåã¯ãåŸãããç®èã®æèç©è³ª
ãçµåããèœåãèããæžå°ããã®ã¿ã§ãªããç®
è圢ææ§ãæªããªãã®ã§ã(C)æåã®å²åã¯ïŒã
200éééšã奜ãŸããã¯ïŒã150éééšãç¹ã«å¥œãŸ
ããã¯ã20ã100éééšã§ããããšãå¿ èŠã§ããã
æ¬çºæã«ãããŠã¯ã«ããŒãã«ã®å
å£ãŸãã¯å€å£
äžã«åœ¢æããããç®èã«æªåå¿ã®ç¡æ°Žãã¬ã€ã³é ž
ã®åºãæ®ããŠããããšãå¿ èŠã§ããããã®ããã«
ã¯ãããšãã°åå¿ã«äŸããç¡æ°Žãã¬ã€ã³é žãš(C)æ
åã®å®èœåºã®æ¯ãåå¿æž©åºŠãåå¿æéãé©å®èª¿ç¯
ããã°ããããããã調æŽããããšã«ããå å£ãŸ
ãã¯å€å£äžã«åœ¢æãããç®èã«åžæããéã®æªå
å¿ã®ç¡æ°Žãã¬ã€ã³é žåºãæ®ãããšãã§ããã
äžã«åœ¢æããããç®èã«æªåå¿ã®ç¡æ°Žãã¬ã€ã³é ž
ã®åºãæ®ããŠããããšãå¿ èŠã§ããããã®ããã«
ã¯ãããšãã°åå¿ã«äŸããç¡æ°Žãã¬ã€ã³é žãš(C)æ
åã®å®èœåºã®æ¯ãåå¿æž©åºŠãåå¿æéãé©å®èª¿ç¯
ããã°ããããããã調æŽããããšã«ããå å£ãŸ
ãã¯å€å£äžã«åœ¢æãããç®èã«åžæããéã®æªå
å¿ã®ç¡æ°Žãã¬ã€ã³é žåºãæ®ãããšãã§ããã
æ¬çºæã«ãããŠã¯ãã€ãã§ãäžèšã®ããã«ããŠ
åŸãããç®èã®ç¡æ°Žãã¬ã€ã³é žåºã®äžéšãŸãã¯å š
éšãå æ°Žå解ããããšãå¿ èŠã§ãããå æ°Žå解
ã¯ãäŸãã°ãç®èã®åœ¢æãããã«ããŒãã«ã10ã
100âã奜ãŸããã¯40ã100âã®æ°Žäžã«ïŒåã48æ
éçšåºŠã奜ãŸããã¯ïŒã10æéçšåºŠæµžæŒ¬ããããš
ã«ãã€ãŠéæãããã
åŸãããç®èã®ç¡æ°Žãã¬ã€ã³é žåºã®äžéšãŸãã¯å š
éšãå æ°Žå解ããããšãå¿ èŠã§ãããå æ°Žå解
ã¯ãäŸãã°ãç®èã®åœ¢æãããã«ããŒãã«ã10ã
100âã奜ãŸããã¯40ã100âã®æ°Žäžã«ïŒåã48æ
éçšåºŠã奜ãŸããã¯ïŒã10æéçšåºŠæµžæŒ¬ããããš
ã«ãã€ãŠéæãããã
æ¬çºæã«ãããŠã¯ãã€ãã§ãäžèšã®ããã«ããŠ
åŠçããç®èã«æèç©è³ªãçµåãããããšãå¿ èŠ
ã§ãããç®èã«æèç©è³ªãçµåãããã«ã¯ãäŸã
ã°æèç©è³ªã溶液ç¶æ ã奜ãŸããã¯æ°Žæº¶æ¶²ç¶æ ã«
ããŠããã®æº¶æ¶²ãã«ããŒãã«ã«ã¹ãã¬ãŒããæ¹
æ³ããã®æº¶æ¶²ãã«ããŒãã«å ã«åŸªç°ãããæ¹æ³ã
ãã®æº¶æ¶²ã«ã«ããŒãã«ã浞挬ãããšãã€ãæ¹æ³ã
æ¡çšããããšãã§ãããæèç©è³ªã®çµåã¯å¥œãŸã
ãã¯â10ã60âãç¹ã«å¥œãŸããã¯ïŒã50âã®æž©åºŠ
ã§æ°ç§ã72æéã奜ãŸããã¯ïŒåã48æéè¡ãªã
ããã
åŠçããç®èã«æèç©è³ªãçµåãããããšãå¿ èŠ
ã§ãããç®èã«æèç©è³ªãçµåãããã«ã¯ãäŸã
ã°æèç©è³ªã溶液ç¶æ ã奜ãŸããã¯æ°Žæº¶æ¶²ç¶æ ã«
ããŠããã®æº¶æ¶²ãã«ããŒãã«ã«ã¹ãã¬ãŒããæ¹
æ³ããã®æº¶æ¶²ãã«ããŒãã«å ã«åŸªç°ãããæ¹æ³ã
ãã®æº¶æ¶²ã«ã«ããŒãã«ã浞挬ãããšãã€ãæ¹æ³ã
æ¡çšããããšãã§ãããæèç©è³ªã®çµåã¯å¥œãŸã
ãã¯â10ã60âãç¹ã«å¥œãŸããã¯ïŒã50âã®æž©åºŠ
ã§æ°ç§ã72æéã奜ãŸããã¯ïŒåã48æéè¡ãªã
ããã
æ¬çºæã®æ¹æ³ã«ãã€ãŠè£œé ãããå°å°¿ã«ããŒã
ã«ã¯ãå°¿è·¯ææãé²æ¢ããããã§çæ³çãªç¹æ§ã
æãããããªãã¡å°å°¿ã«ããŒãã«ãäœå ã«ç眮ã
ããæéãšããŠã¯ãïŒãïŒæ¥ã®å Žåãæãå€ãã
é·ãå Žåã§ïŒé±éçšåºŠã§ããããããŸãã«ïŒé±é
çšåºŠã«ãããã€ãŠç眮ãããå Žåãæãããæ¬çº
æã®æ¹æ³ã«ãã€ãŠè£œé ããå°å°¿ã«ããŒãã«ã¯ãã®
ãããªæéã«ããã€ãŠåŸã ã«æèç©è³ªãå°¿äžã«æŸ
åºãããšããçæ³çãªç¹æ§ãæãããããã«ã¯æŸ
åºã®éã«é¢ããŠãçæ³çãªç¹æ§ãæãããããªã
ã¡ã«ããŒãã«æ¿å ¥åŸïŒæ¥ç®ããããŸã§ãããªãã¡
ã«ããŒãã«æ¿å ¥æã«ã«ããŒãã«ãšãšãã«èè±å ã«
æŒãããŸããå°¿éåžžåšèã®ããã«ç¹ã«ææçãé«
ãæéïŒãã®çšåºŠã®æéæ¿å ¥ãããŠããå Žåãèš
åºçã«ãäžçªå€ãã®ã§ãããïŒã«ãããŠã¯å€éã«
æŸåºããããã®åŸã¯æ«ææŸåºéã¯æžå°ããŠããã
ïŒé±éåŸã«ãããŠãå°¿è·¯ææãé²æ¢ããã«ååãª
éã¯æŸåºããããšããç¹æ§ãæããããã®ãããª
æ«ææžå°ã瀺ããšããç¹æ§ã¯å°¿è·¯ææé²æ¢ã®èŠ³ç¹
ããã¯å¿ ããããå¿ èŠã§ãããšã¯ãããªãããçµ
æžçãªèŠ³ç¹ããã¯å¿ èŠä»¥äžã®æèç©è³ªã䜿ãå¿ èŠ
ããªãç¹ã§æå©ã§ããããŸãæçç©è³ªã䜿çšãã
å Žåã«èµ·ãåŸããå€éã®é£çšã«ããèæ§èã®åºçŸ
ã«ããææé²æ¢èœã®æžéã®å¯èœæ§ãå°ãªãããšã
èããŠãæãŸããç¹æ§ã§ããããã®ãããªç¹æ§ã¯
å°å°¿ã«ããŒãã«ãšããŠçæ³çãªç¹æ§ã§ãããšãã
ãããã®ããšãããå ·äœçã«äŸããããŠèª¬æãã
ãšä»¥äžã®ããšãã§ããã
ã«ã¯ãå°¿è·¯ææãé²æ¢ããããã§çæ³çãªç¹æ§ã
æãããããªãã¡å°å°¿ã«ããŒãã«ãäœå ã«ç眮ã
ããæéãšããŠã¯ãïŒãïŒæ¥ã®å Žåãæãå€ãã
é·ãå Žåã§ïŒé±éçšåºŠã§ããããããŸãã«ïŒé±é
çšåºŠã«ãããã€ãŠç眮ãããå Žåãæãããæ¬çº
æã®æ¹æ³ã«ãã€ãŠè£œé ããå°å°¿ã«ããŒãã«ã¯ãã®
ãããªæéã«ããã€ãŠåŸã ã«æèç©è³ªãå°¿äžã«æŸ
åºãããšããçæ³çãªç¹æ§ãæãããããã«ã¯æŸ
åºã®éã«é¢ããŠãçæ³çãªç¹æ§ãæãããããªã
ã¡ã«ããŒãã«æ¿å ¥åŸïŒæ¥ç®ããããŸã§ãããªãã¡
ã«ããŒãã«æ¿å ¥æã«ã«ããŒãã«ãšãšãã«èè±å ã«
æŒãããŸããå°¿éåžžåšèã®ããã«ç¹ã«ææçãé«
ãæéïŒãã®çšåºŠã®æéæ¿å ¥ãããŠããå Žåãèš
åºçã«ãäžçªå€ãã®ã§ãããïŒã«ãããŠã¯å€éã«
æŸåºããããã®åŸã¯æ«ææŸåºéã¯æžå°ããŠããã
ïŒé±éåŸã«ãããŠãå°¿è·¯ææãé²æ¢ããã«ååãª
éã¯æŸåºããããšããç¹æ§ãæããããã®ãããª
æ«ææžå°ã瀺ããšããç¹æ§ã¯å°¿è·¯ææé²æ¢ã®èŠ³ç¹
ããã¯å¿ ããããå¿ èŠã§ãããšã¯ãããªãããçµ
æžçãªèŠ³ç¹ããã¯å¿ èŠä»¥äžã®æèç©è³ªã䜿ãå¿ èŠ
ããªãç¹ã§æå©ã§ããããŸãæçç©è³ªã䜿çšãã
å Žåã«èµ·ãåŸããå€éã®é£çšã«ããèæ§èã®åºçŸ
ã«ããææé²æ¢èœã®æžéã®å¯èœæ§ãå°ãªãããšã
èããŠãæãŸããç¹æ§ã§ããããã®ãããªç¹æ§ã¯
å°å°¿ã«ããŒãã«ãšããŠçæ³çãªç¹æ§ã§ãããšãã
ãããã®ããšãããå ·äœçã«äŸããããŠèª¬æãã
ãšä»¥äžã®ããšãã§ããã
æ¬çºæã®æ¹æ³ã«ãŠè£œé ããã¢ããã°ãªã³ã·ãç³»
æçç©è³ªãçµåããå°å°¿ã«ããŒãã«ãäžå®éã®å°¿
äžã«37âã«ãŠæµžæŒ¬ããïŒæ¥ããšã«æ°ããåéã®å°¿
ãšåãæããæäœã40æ¥éè¡ãªãæçç©è³ªã®æŸåº
ããã40åã®å°¿ãµã³ãã«ãåŸãåã ã®ãµã³ãã«ã«
ã€ããŠå«æãããæçç©è³ªã®éã枬å®ããçµæã
ïŒæ¥ç®ã®å°¿äžã®æçç©è³ªã¯ã¯1500ã40000ÎŒïœã®
ç¯å²ã§ããã以éïŒæ¥ç®ã1000ã35000ÎŒïœãïŒ
æ¥ç®ã750ã25000ÎŒïœãïŒãïŒæ¥ç®ã500ã
20000ÎŒïœãïŒãïŒæ¥ç®ã250ã15000ÎŒïœãïŒã10
æ¥ç®ã250ã10000ÎŒïœã11ã14æ¥ç®ã250ã7500ÎŒ
ïœã15ã30æ¥ç®ã150ã5000ÎŒïœã31ã40æ¥ç®ã
100ã2500ÎŒïœã§ãã€ãã以äžã®ããã«ïŒãïŒæ¥
ç®ã®æŸåºéã¯å€ããæäœã®å Žåã§ã500ÎŒïœä»¥äž
æŸåºãããŠããããŸã14æ¥ç®ãŸã§ã¯250ÎŒïœä»¥äž
ã¯æŸåºãããŠããã31ã40æ¥ç®ã«ãããŠãææé²
æ¢èœåãæã€ãšèããããçšåºŠã®éãæŸåºãããŠ
ããã
æçç©è³ªãçµåããå°å°¿ã«ããŒãã«ãäžå®éã®å°¿
äžã«37âã«ãŠæµžæŒ¬ããïŒæ¥ããšã«æ°ããåéã®å°¿
ãšåãæããæäœã40æ¥éè¡ãªãæçç©è³ªã®æŸåº
ããã40åã®å°¿ãµã³ãã«ãåŸãåã ã®ãµã³ãã«ã«
ã€ããŠå«æãããæçç©è³ªã®éã枬å®ããçµæã
ïŒæ¥ç®ã®å°¿äžã®æçç©è³ªã¯ã¯1500ã40000ÎŒïœã®
ç¯å²ã§ããã以éïŒæ¥ç®ã1000ã35000ÎŒïœãïŒ
æ¥ç®ã750ã25000ÎŒïœãïŒãïŒæ¥ç®ã500ã
20000ÎŒïœãïŒãïŒæ¥ç®ã250ã15000ÎŒïœãïŒã10
æ¥ç®ã250ã10000ÎŒïœã11ã14æ¥ç®ã250ã7500ÎŒ
ïœã15ã30æ¥ç®ã150ã5000ÎŒïœã31ã40æ¥ç®ã
100ã2500ÎŒïœã§ãã€ãã以äžã®ããã«ïŒãïŒæ¥
ç®ã®æŸåºéã¯å€ããæäœã®å Žåã§ã500ÎŒïœä»¥äž
æŸåºãããŠããããŸã14æ¥ç®ãŸã§ã¯250ÎŒïœä»¥äž
ã¯æŸåºãããŠããã31ã40æ¥ç®ã«ãããŠãææé²
æ¢èœåãæã€ãšèããããçšåºŠã®éãæŸåºãããŠ
ããã
æ¬çºæã«ãããŠã¯ãçšãã(A)æåã(B)æåã(C)
æåã®çš®é¡ããã³å°å°¿ã«ããŒãã«ã®çŽ æãªã©ã«ã
ã€ãŠã¯å¿ èŠã«å¿ããŠæ¥çå€ãçšããŠ(A)æåãš(B)æ
åãš(C)æåãšã®åå¿çæç©ãããªãç®èãšãã«ã
ãŒãã«ãšãæ¥çãããããšãå¯èœã§ãããæ¥çã
ããæ¹æ³ãšããŠã¯ãäŸãã°ãããããã«ããŒãã«
ã®å å£ãŸãã¯å€å£ã«æ¥çå€ã®å±€ãèšããŠãããã
ã®å±€ã®è¡šé¢äžã§åæåãåå¿ãããæ¹æ³ãæ¥çå€
ãåæåã®æ··åç©ã«ãããããæ··åããŠããæ¹æ³
ãªã©ãæ¡çšããããšãã§ããã
æåã®çš®é¡ããã³å°å°¿ã«ããŒãã«ã®çŽ æãªã©ã«ã
ã€ãŠã¯å¿ èŠã«å¿ããŠæ¥çå€ãçšããŠ(A)æåãš(B)æ
åãš(C)æåãšã®åå¿çæç©ãããªãç®èãšãã«ã
ãŒãã«ãšãæ¥çãããããšãå¯èœã§ãããæ¥çã
ããæ¹æ³ãšããŠã¯ãäŸãã°ãããããã«ããŒãã«
ã®å å£ãŸãã¯å€å£ã«æ¥çå€ã®å±€ãèšããŠãããã
ã®å±€ã®è¡šé¢äžã§åæåãåå¿ãããæ¹æ³ãæ¥çå€
ãåæåã®æ··åç©ã«ãããããæ··åããŠããæ¹æ³
ãªã©ãæ¡çšããããšãã§ããã
以äžã«å®æœäŸããããŠæ¬çºæãããã«å
·äœçã«
説æããããªããäŸäžã®ãéšãã¯ãéééšããæ
å³ããã
説æããããªããäŸäžã®ãéšãã¯ãéééšããæ
å³ããã
å®æœäŸ ïŒ
Gantrez AN169ïŒGAF瀟補ãã¡ãã«ããã«ãš
ãŒãã«ãšç¡æ°Žãã¬ã€ã³é žã®å ±éåäœïŒïŒéšãšã
SMA3000ïŒARCO Chemical瀟補ãã¹ãã¬ã³ãšç¡
æ°Žãã¬ã€ã³é žã®å ±éåäœïŒïŒéšãšããã°ããŽãŒã«
400ïŒæŸæ¬æ²¹è瀟補ãããªãšãã¬ã³ã°ãªã³ãŒã«ïŒïŒ
éšãšã27éšã®ã¢ã»ãã³ã«æº¶è§£ãã溶液ã«ãã·ãªã³
ãŒã³å°å°¿ã«ããŒãã«ãæ¥æ¬ã·ã€ãŒããã瀟補ãã¢
ãŒã¬ã€ã«ã»ã·ãªã³ãŒã³ã»ããªãŒãªãŒã»ã«ããŒã
ã«ãã宀枩ã«ãŠïŒåé浞挬ããåŸãåãåºã60â
ã«ãŠïŒæé也ç¥ããããã«140âã«ãŠïŒæéç±åŠ
çãæœãããŠå å€å£ã«GantreZãSMAããã°ã
ãŽãŒã«ã®åå¿çæç©ãããªãç®èãæããã«ããŒ
ãã«ãåŸãããã®ããã«ããŠåŸãã«ããŒãã«ã70
âã®æ°Žäžã«ïŒæé浞挬ããåŸãåãåºããŠé¢šä¹Ÿ
ããã€ãã§ç¡«é žãžãã«ã·ã³æ°Žæº¶æ¶²ã150mgïŒå
䟡ïŒïŒ100mlãã«PHã0.1Nã®æ°Žé žåãããªãŠã
ãçšããŠïŒã«èª¿æŽããªããïŒâã«ãŠïŒæé浞挬ã
ãŠãç¡«é žãžãã«ã·ã³ãçµåãããã«ããŒãã«ãåŸ
ãã
ãŒãã«ãšç¡æ°Žãã¬ã€ã³é žã®å ±éåäœïŒïŒéšãšã
SMA3000ïŒARCO Chemical瀟補ãã¹ãã¬ã³ãšç¡
æ°Žãã¬ã€ã³é žã®å ±éåäœïŒïŒéšãšããã°ããŽãŒã«
400ïŒæŸæ¬æ²¹è瀟補ãããªãšãã¬ã³ã°ãªã³ãŒã«ïŒïŒ
éšãšã27éšã®ã¢ã»ãã³ã«æº¶è§£ãã溶液ã«ãã·ãªã³
ãŒã³å°å°¿ã«ããŒãã«ãæ¥æ¬ã·ã€ãŒããã瀟補ãã¢
ãŒã¬ã€ã«ã»ã·ãªã³ãŒã³ã»ããªãŒãªãŒã»ã«ããŒã
ã«ãã宀枩ã«ãŠïŒåé浞挬ããåŸãåãåºã60â
ã«ãŠïŒæé也ç¥ããããã«140âã«ãŠïŒæéç±åŠ
çãæœãããŠå å€å£ã«GantreZãSMAããã°ã
ãŽãŒã«ã®åå¿çæç©ãããªãç®èãæããã«ããŒ
ãã«ãåŸãããã®ããã«ããŠåŸãã«ããŒãã«ã70
âã®æ°Žäžã«ïŒæé浞挬ããåŸãåãåºããŠé¢šä¹Ÿ
ããã€ãã§ç¡«é žãžãã«ã·ã³æ°Žæº¶æ¶²ã150mgïŒå
䟡ïŒïŒ100mlãã«PHã0.1Nã®æ°Žé žåãããªãŠã
ãçšããŠïŒã«èª¿æŽããªããïŒâã«ãŠïŒæé浞挬ã
ãŠãç¡«é žãžãã«ã·ã³ãçµåãããã«ããŒãã«ãåŸ
ãã
ãã®ãã®ãç¡èäžã§37âã®è©Šéšå°¿äžã«æµžæŒ¬ãã
ïŒæ¥çµéåŸãè©Šéšèã«Bacillus Subtilis
ATCC6633ãçšããŠåçå¹³æ¿æ³ã«ãŠåçå¹³æ¿ã«è©Š
éšå°¿ãïŒãïŒæ»Žèœäžãããããšã«ãããã®å°¿ã®æ
è掻æ§ãã¹ããè¡ã€ããšããé»æ¢åãçããè©Šéš
å°¿äžã«æŽ»æ§ãªæçç©è³ªãååšããããšã確èªãã
ããããã«è©Šéšå°¿ãïŒæ¥ããšã«æ°ããè©Šéšå°¿ã«å
ã代ããŠåæ§ã®æŽ»æ§ã¹ããç¹°ãè¿ãè¡ã€ããšã
ãã40æ¥ç®ã«æ¡åããè©Šéšå°¿ã«ã€ããŠãé»æ¢åã
çãã掻æ§ãæã€ããšã確èªãããã
ïŒæ¥çµéåŸãè©Šéšèã«Bacillus Subtilis
ATCC6633ãçšããŠåçå¹³æ¿æ³ã«ãŠåçå¹³æ¿ã«è©Š
éšå°¿ãïŒãïŒæ»Žèœäžãããããšã«ãããã®å°¿ã®æ
è掻æ§ãã¹ããè¡ã€ããšããé»æ¢åãçããè©Šéš
å°¿äžã«æŽ»æ§ãªæçç©è³ªãååšããããšã確èªãã
ããããã«è©Šéšå°¿ãïŒæ¥ããšã«æ°ããè©Šéšå°¿ã«å
ã代ããŠåæ§ã®æŽ»æ§ã¹ããç¹°ãè¿ãè¡ã€ããšã
ãã40æ¥ç®ã«æ¡åããè©Šéšå°¿ã«ã€ããŠãé»æ¢åã
çãã掻æ§ãæã€ããšã確èªãããã
ããã«äžèšã®ããšãã«ããŠåŸãããè©Šéšå°¿äžã«
æŸåºãããç¡«é žãžãã«ã·ã³éãâãããããã³
âïŒã¹ã«ãã³é žãããªãŠã ã«ããåè²å®éæ³ã«ãŠ
枬å®ãããšããïŒæ¥ç®ã32000ÎŒïœãïŒæ¥ç®ã
28000ÎŒïœãïŒæ¥ç®ã23000ÎŒïœãïŒæ¥ç®ã10000ÎŒ
ïœãïŒæ¥ç®ã7500ÎŒïœã14æ¥ç®ã5000ÎŒïœã35æ¥
ç®ã1000ÎŒïœã§ãã€ãã
æŸåºãããç¡«é žãžãã«ã·ã³éãâãããããã³
âïŒã¹ã«ãã³é žãããªãŠã ã«ããåè²å®éæ³ã«ãŠ
枬å®ãããšããïŒæ¥ç®ã32000ÎŒïœãïŒæ¥ç®ã
28000ÎŒïœãïŒæ¥ç®ã23000ÎŒïœãïŒæ¥ç®ã10000ÎŒ
ïœãïŒæ¥ç®ã7500ÎŒïœã14æ¥ç®ã5000ÎŒïœã35æ¥
ç®ã1000ÎŒïœã§ãã€ãã
æ¯èŒäŸ ïŒ
70âã®æ°Žäžã«ïŒæé浞挬ãããšããæäœãè¡ãª
ããªãã€ã以å€ã¯å®æœäŸïŒãšå šãåæ§ã«ããŠåŸã
ããã«ããŒãã«ã«ã€ããŠå®æœäŸïŒãšåæ§ã®ãã¹ã
ãè¡ã€ããšããé»æ¢åã¯å šãçããªãã€ãã
ããªãã€ã以å€ã¯å®æœäŸïŒãšå šãåæ§ã«ããŠåŸã
ããã«ããŒãã«ã«ã€ããŠå®æœäŸïŒãšåæ§ã®ãã¹ã
ãè¡ã€ããšããé»æ¢åã¯å šãçããªãã€ãã
æ¯èŒäŸ ïŒ
ïŒéšã®Gantrez AN169ãšïŒéšã®ãã°ããŽãŒã«
400ã27éšã®ã¢ã»ãã³ã«æº¶è§£ãã溶液ãçšããä»
ã¯å®æœäŸïŒãšå šãåæ§ã«ããŠç¡«é žãžãã«ã·ã³ã®çµ
åãããã«ããŒãã«ãåŸãããã®ãã®ã«ã€ããŠå®
æœäŸïŒãšåæ§ã®ãã¹ããè¡ã€ããšãã10æ¥ç®ãã
ãããç®èã®æº¶è§£ãèªããããå®éã®å¿çšã«ã¯äž
é©åœãšå€æãããã
400ã27éšã®ã¢ã»ãã³ã«æº¶è§£ãã溶液ãçšããä»
ã¯å®æœäŸïŒãšå šãåæ§ã«ããŠç¡«é žãžãã«ã·ã³ã®çµ
åãããã«ããŒãã«ãåŸãããã®ãã®ã«ã€ããŠå®
æœäŸïŒãšåæ§ã®ãã¹ããè¡ã€ããšãã10æ¥ç®ãã
ãããç®èã®æº¶è§£ãèªããããå®éã®å¿çšã«ã¯äž
é©åœãšå€æãããã
æ¯èŒäŸ ïŒ
ïŒéšã®SMA3000ãšïŒéšã®ãã°ããŽãŒã«400ã27
éšã®ã¢ã»ãã³ã«æº¶è§£ãã溶液ãçšããä»ã¯å®æœäŸ
ïŒãšå šãåæ§ã«ããŠåŸãã«ããŒãã«ã®ç®èã¯åäž
æ§ã«ä¹ãããã®ã§ãã€ãããŸãããã®ãã®ãçšã
ãŠå®æœäŸïŒãšåæ§ã«ããŠç¡«é žãžãã«ã·ã³ãçµåã
ããããã®ã«ã€ããŠå®æœäŸïŒãšåæ§ã®ãã¹ããè¡
ã€ããšããïŒæ¥ç®ã®è©Šéšå°¿ã«ã€ããŠãã¯ãé»æ¢å
ãçããªãã€ãã
éšã®ã¢ã»ãã³ã«æº¶è§£ãã溶液ãçšããä»ã¯å®æœäŸ
ïŒãšå šãåæ§ã«ããŠåŸãã«ããŒãã«ã®ç®èã¯åäž
æ§ã«ä¹ãããã®ã§ãã€ãããŸãããã®ãã®ãçšã
ãŠå®æœäŸïŒãšåæ§ã«ããŠç¡«é žãžãã«ã·ã³ãçµåã
ããããã®ã«ã€ããŠå®æœäŸïŒãšåæ§ã®ãã¹ããè¡
ã€ããšããïŒæ¥ç®ã®è©Šéšå°¿ã«ã€ããŠãã¯ãé»æ¢å
ãçããªãã€ãã
å®æœäŸ ïŒãïŒ
ïŒéšã®Gantrez AN169ãš95éšã®SMA3000ãš30
éšã®ããªãšãã¬ã³ã°ãªã³ãŒã«ã900éšã®ã¢ã»ãã³
ã«æº¶è§£ãã溶液ãçšããä»ã¯å®æœäŸïŒãšåæ§ã«ã
ãŠåŸãã«ããŒãã«ïŒæ¬ãã60âã®æ°Žäžã«ïŒæé浞
挬ããåŸãïŒæ¬ãã²ã³ã¿ãã€ã·ã³æ°Žæº¶æ¶²ã150mg
ïŒå䟡ïŒïŒ100mlãã«ãä»ã®ïŒæ¬ãããªããã·ã³ïŒ¢
氎溶液ã100äžåäœïŒ100mlãã«ãæ®ãã®ïŒæ¬ãã
ã©ãžãªãã€ã·ã³æ°Žæº¶æ¶²ã150mgïŒå䟡ïŒïŒ100mlã
ã«25âã«ãŠïŒæé浞挬ãããã浞挬åŸã®ïŒæ¬ã®ã«
ããŒãã«ã«ã€ããŠåã ã®æçç©è³ªã«å¯Ÿå¿ããè©Šéš
èãçšããŠå®æœäŸïŒãšåæ§ã®ãã¹ããè¡ã€ããšã
ããã¹ãŠã®ã«ããŒãã«ã«ã€ããŠåŸããã40æ¥ç®ã®
è©Šéšå°¿ã¯é»æ¢åãçããã
éšã®ããªãšãã¬ã³ã°ãªã³ãŒã«ã900éšã®ã¢ã»ãã³
ã«æº¶è§£ãã溶液ãçšããä»ã¯å®æœäŸïŒãšåæ§ã«ã
ãŠåŸãã«ããŒãã«ïŒæ¬ãã60âã®æ°Žäžã«ïŒæé浞
挬ããåŸãïŒæ¬ãã²ã³ã¿ãã€ã·ã³æ°Žæº¶æ¶²ã150mg
ïŒå䟡ïŒïŒ100mlãã«ãä»ã®ïŒæ¬ãããªããã·ã³ïŒ¢
氎溶液ã100äžåäœïŒ100mlãã«ãæ®ãã®ïŒæ¬ãã
ã©ãžãªãã€ã·ã³æ°Žæº¶æ¶²ã150mgïŒå䟡ïŒïŒ100mlã
ã«25âã«ãŠïŒæé浞挬ãããã浞挬åŸã®ïŒæ¬ã®ã«
ããŒãã«ã«ã€ããŠåã ã®æçç©è³ªã«å¯Ÿå¿ããè©Šéš
èãçšããŠå®æœäŸïŒãšåæ§ã®ãã¹ããè¡ã€ããšã
ããã¹ãŠã®ã«ããŒãã«ã«ã€ããŠåŸããã40æ¥ç®ã®
è©Šéšå°¿ã¯é»æ¢åãçããã
å®æœäŸ ïŒ
ç¡æ°Žãã¬ã€ã³é
žãšãšãã¬ã³ã®å
±éåäœïŒå
±éå
æ¯ïŒïŒïŒãååé50äžïŒïŒéšãšç¡æ°Žãã¬ã€ã³é žãš
ãšãã«ããã«ãšãŒãã«ã®å ±éåäœïŒå ±éåæ¯ïŒïŒ
ïŒãååé50äžïŒïŒéšãšããå床99.9ã¢ã«ïŒ éå
床1700ã®ããªããã«ã¢ã«ã³ãŒã«0.5éšãšã10éšã®
ã¢ã»ãã³ã«æº¶è§£ãã溶液ãã倩ç¶ãŽã å°å°¿ã«ããŒ
ãã«ãæ¥æ¬ã·ã€ãŒãŠãã瀟補ãã¢ãŒã¬ã€ã«ã»ããª
ãŒãªãŒã»ã«ããŒãã«ãã®å éšã«ããªã¹ã¿ãã³ãã
çšããŠå®€æž©ã«ãŠïŒmlïŒåã®é床ã«ãŠïŒæé埪ç°ã
ããåŸã80âã«ãŠïŒæé也ç¥ããããã«150âã«
ãŠïŒæéç±åŠçãè¡ã€ãŠãã«ããŒãã«å å£ã«ç®è
ã圢æããããããã®ããã«ããŠåŸãã«ããŒãã«
ã60âã®æ°Žäžã«ïŒæé浞挬ããåŸãåãåºããŠé¢š
也ãããã®ãã®ãã¢ã¯ãªããŒã«ã®1wtïŒ æ°Žæº¶æ¶²ã«
宀枩ã«ãŠïŒæé浞挬ããŠã¢ã¯ãªããŒã«ãçµåãã
ãã«ããŒãã«ãåŸããåŸãããã«ããŒãã«ãçšã
ãŠå®æœäŸïŒãšå šãåæ§ã®ãã¹ããè¡ã€ããšãã40
æ¥ç®ã®è©Šéšå°¿ã¯é»æ¢åãçããã
æ¯ïŒïŒïŒãååé50äžïŒïŒéšãšç¡æ°Žãã¬ã€ã³é žãš
ãšãã«ããã«ãšãŒãã«ã®å ±éåäœïŒå ±éåæ¯ïŒïŒ
ïŒãååé50äžïŒïŒéšãšããå床99.9ã¢ã«ïŒ éå
床1700ã®ããªããã«ã¢ã«ã³ãŒã«0.5éšãšã10éšã®
ã¢ã»ãã³ã«æº¶è§£ãã溶液ãã倩ç¶ãŽã å°å°¿ã«ããŒ
ãã«ãæ¥æ¬ã·ã€ãŒãŠãã瀟補ãã¢ãŒã¬ã€ã«ã»ããª
ãŒãªãŒã»ã«ããŒãã«ãã®å éšã«ããªã¹ã¿ãã³ãã
çšããŠå®€æž©ã«ãŠïŒmlïŒåã®é床ã«ãŠïŒæé埪ç°ã
ããåŸã80âã«ãŠïŒæé也ç¥ããããã«150âã«
ãŠïŒæéç±åŠçãè¡ã€ãŠãã«ããŒãã«å å£ã«ç®è
ã圢æããããããã®ããã«ããŠåŸãã«ããŒãã«
ã60âã®æ°Žäžã«ïŒæé浞挬ããåŸãåãåºããŠé¢š
也ãããã®ãã®ãã¢ã¯ãªããŒã«ã®1wtïŒ æ°Žæº¶æ¶²ã«
宀枩ã«ãŠïŒæé浞挬ããŠã¢ã¯ãªããŒã«ãçµåãã
ãã«ããŒãã«ãåŸããåŸãããã«ããŒãã«ãçšã
ãŠå®æœäŸïŒãšå šãåæ§ã®ãã¹ããè¡ã€ããšãã40
æ¥ç®ã®è©Šéšå°¿ã¯é»æ¢åãçããã
Claims (1)
- ïŒ ãªã¬ãã€ã³ç³»éåäœãŸãã¯ãžãšã³ç³»éåäœãŸ
ãã¯ã·ãªã³ã³ç³»éåäœãçŽ æãšããå°å°¿ã«ããŒã
ã«ã®å å£ãŸãã¯å€å£ã«ãããŠã(A)ç¡æ°Žãã¬ã€ã³é ž
ãšãããšå ±éåãåŸãè³éŠæããã«ã¢ãããŒãŸã
ã¯ãªã¬ãã€ã³ã¢ãããŒãšã®å ±éåäœ0.5ã99.5é
ééšãšã(B)ç¡æ°Žãã¬ã€ã³é žãšãããšå ±éåãåŸã
èèªæããã«ãšãŒãã«ãŸãã¯èèªæããã«ãšã¹ã
ã«ãšã®å ±éåäœ0.5ã99.5éééšãšã(A)æåãšïŒ¢
æåã®åèšé100éééšã«å¯ŸãïŒã200éééšã®(C)
å€å®èœæ§ååç©ãšãåå¿ãããŠã該å å£ãŸãã¯å€
å£äžã«æªåå¿ã®ç¡æ°Žãã¬ã€ã³é žåºãæããç®èã
圢æããããã€ãã§è©²ç¡æ°Žãã¬ã€ã³é žåºã®äžéšãŸ
ãã¯å šéšãå æ°Žå解ããã®ã¡è©²ç®èã«æèç©è³ªã
çµåãããããšãç¹åŸŽãšããå°¿è·¯ææé²æ¢èœãæ
ããå°å°¿ã«ããŒãã«ã®è£œé æ¹æ³ã
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56182729A JPS5883971A (ja) | 1981-11-13 | 1981-11-13 | å°¿è·¯ææé²æ¢èœãæããå°å°¿ã«ãâãã«ã®è£œé æ¹æ³ |
| DE8282302725T DE3272706D1 (en) | 1981-05-27 | 1982-05-27 | Urethral catheter capable of preventing urinary tract infection and process for producing the same |
| EP82302725A EP0065884B1 (en) | 1981-05-27 | 1982-05-27 | Urethral catheter capable of preventing urinary tract infection and process for producing the same |
| US06/382,743 US4539234A (en) | 1981-05-27 | 1982-05-27 | Urethral catheter capable of preventing urinary tract infection and process for producing the same |
| US06/734,726 US4642104A (en) | 1981-05-27 | 1985-06-14 | Urethral catheter capable of preventing urinary tract infection and process for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56182729A JPS5883971A (ja) | 1981-11-13 | 1981-11-13 | å°¿è·¯ææé²æ¢èœãæããå°å°¿ã«ãâãã«ã®è£œé æ¹æ³ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5883971A JPS5883971A (ja) | 1983-05-19 |
| JPH0224544B2 true JPH0224544B2 (ja) | 1990-05-29 |
Family
ID=16123417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56182729A Granted JPS5883971A (ja) | 1981-05-27 | 1981-11-13 | å°¿è·¯ææé²æ¢èœãæããå°å°¿ã«ãâãã«ã®è£œé æ¹æ³ |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5883971A (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6040061A (ja) * | 1983-08-12 | 1985-03-02 | ãŠããã«æ ªåŒäŒç€Ÿ | æèå€åŸæŸæ§å°å°¿ã«ãâãã« |
| JPS61122869A (ja) * | 1984-11-16 | 1986-06-10 | ãã«ã¢æ ªåŒäŒç€Ÿ | å»ççšå ·ããã³ãã®è£œé æ¹æ³ |
| US4895566A (en) * | 1986-07-25 | 1990-01-23 | C. R. Bard, Inc. | Coating medical devices with cationic antibiotics |
| WO2015023168A1 (ru) | 2013-11-06 | 2015-02-19 | ЧаÑÑМПе УÑÑежЎеМОе "ÐазаÑбаев УМОвеÑÑОÑÐµÑ Ð ÐžÑÐµÑ ÐМЎ ÐММПвÑйÑÐœ СОÑÑÑÐŒ" | ÐПЎМÑй лОÑОй-ОПММÑй аккÑÐŒÑлÑÑÐŸÑ |
-
1981
- 1981-11-13 JP JP56182729A patent/JPS5883971A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5883971A (ja) | 1983-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4642104A (en) | Urethral catheter capable of preventing urinary tract infection and process for producing the same | |
| JPH10328293A (ja) | å»ççšå ·åã³ãã®è£œé æ¹æ³ | |
| CN101212906B (zh) | çšäºåšå»çè£ çœ®äžæå¶åŸ®çç©èèççé¿åå¢æ®çæ埮çç©ç»åç© | |
| AU705101B2 (en) | Bioresponsive pharmacologically-active polymers and articles made therefrom | |
| JP4585687B2 (ja) | 现èæ¥çäœæžåã³é²æ¢çšçç©éååŠçã³ãŒãã£ã³ã° | |
| US6416546B1 (en) | Medical device and production method thereof | |
| US20050175669A1 (en) | Highly lubricious hydrophilic coating utilizing dendrimers | |
| EP1175148B1 (en) | Infection resistant polymers, their preparation and uses | |
| JP2008119499A (ja) | åºäœã«èŠªæ°Žæ§è¢«èã圢æããæ¹æ³ããã³ãã®ãããªè¢«èãåããåºäœãç¹ã«å»ççšè£ 眮 | |
| Lakshmi et al. | Bacterial adhesion onto azidated poly (vinyl chloride) surfaces | |
| EP1979010B1 (en) | Biological wound dressing and method of making | |
| JPH0224544B2 (ja) | ||
| WO1997045066A1 (en) | Urinary medical devices | |
| CN114177359B (zh) | äžç§æèæ¶å±åå ¶å¶å€æ¹æ³ååºçš | |
| JP2013515534A (ja) | æµäœæäžè£ 眮ã®è¡šé¢ãåŠçããåŠçæ¹æ³ | |
| JPH10328294A (ja) | å»ççšå ·åã³ãã®è£œé æ¹æ³ | |
| JPS6036064A (ja) | æèç©è³ªåŸæŸæ§å°å°¿ã«ãâãã«ã®è£œé æ¹æ³ | |
| JP2003299726A (ja) | äœå æ¿å ¥å»ççšå ·åã³ãã®è£œé æ¹æ³ | |
| JP3776194B2 (ja) | å»ççšå ·åã³ãã®è£œé æ¹æ³ | |
| JPH0225625B2 (ja) | ||
| JP2003299725A (ja) | äœå æ¿å ¥å»ççšå ·åã³ãã®è£œé æ¹æ³ | |
| JPS61122869A (ja) | å»ççšå ·ããã³ãã®è£œé æ¹æ³ | |
| JP2001276210A (ja) | æèæ§å»ççšå ·åã³ãã®è£œé æ¹æ³ | |
| JP2001276211A (ja) | çç掻æ§ãæããæèæ§å»ççšå ·åã³ãã®è£œé æ¹æ³ | |
| JPS5995058A (ja) | å°å°¿ã«ãâãã«ã®è£œé æ¹æ³ |